data_1aml_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aml _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -78.11 -59.68 2.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.8 t -50.25 -75.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.94 -42.16 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.582 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.4 t80 -62.6 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.1 -47.49 6.08 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.599 0.714 . . . . 0.0 109.673 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' OE2' ' CG1' ' A' ' 18' ' ' VAL . 51.0 mt-10 -56.47 -46.91 80.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.653 -0.654 . . . . 0.0 109.969 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.364 0.602 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -27.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.379 -0.826 . . . . 0.0 109.407 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.567 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.8 pt -59.44 -46.86 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.82 -25.11 21.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 mt -79.49 -67.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -1.194 . . . . 0.0 109.773 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.5 ptp -50.37 -21.08 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.61 -0.681 . . . . 0.0 109.703 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 91.7 t -88.45 28.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.618 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.85 -52.1 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.3 t -52.18 -76.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.33 -42.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.62 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.0 t80 -63.0 -61.63 2.26 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.01 -46.4 8.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.674 0.749 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.9 mt-10 -57.73 -43.11 85.09 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.826 -0.546 . . . . 0.0 109.934 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.907 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.261 0.553 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 31' ' ' ILE . 2.7 mp -54.53 -19.87 4.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.219 -0.926 . . . . 0.0 109.887 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 33' ' ' GLY . 14.5 mt -64.71 -45.91 93.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.229 -0.919 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -44.64 -31.4 2.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -65.54 -77.55 0.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.437 -1.037 . . . . 0.0 109.928 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.492 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 1.8 ptt? -40.53 -26.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.814 -0.554 . . . . 0.0 110.285 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 78.3 t -84.15 30.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 110.208 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.861 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.449 0.642 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.53 -64.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -50.04 -71.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.542 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.11 -41.88 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.443 179.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.587 ' N ' ' O ' ' A' ' 18' ' ' VAL . 16.3 t80 -66.01 -63.67 1.03 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -49.22 -49.31 43.62 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.595 0.712 . . . . 0.0 110.192 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.08 -37.21 74.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.755 -0.591 . . . . 0.0 109.991 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.205 0.526 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.7 mp -96.92 -22.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -93.13 -38.05 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' HD13 ' A' ' 32' ' ' ILE . . . -76.4 1.66 60.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 33' ' ' GLY . 36.0 mt -122.24 -49.87 2.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.444 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 18.4 ptm -54.58 -38.16 66.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.76 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 78.5 t -86.76 30.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.241 0.543 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -63.4 -55.66 22.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.4 t -50.76 -76.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.538 ' C ' ' O ' ' A' ' 18' ' ' VAL . 2.7 t80 -27.24 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.794 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 18' ' ' VAL . 12.6 t80 -63.68 -61.11 2.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -48.51 12.03 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.74 0.781 . . . . 0.0 109.618 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 55.8 mt-10 -58.37 -39.51 79.81 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.646 -0.659 . . . . 0.0 109.898 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.56 -33.75 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.27 -0.893 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 4.9 pt -64.68 -48.51 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 108.836 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -54.56 -29.47 48.22 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.49 -70.13 0.16 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.519 -0.989 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.8 ptt? -48.58 -31.46 6.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.743 -0.598 . . . . 0.0 109.807 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 36' ' ' VAL . 42.8 t -86.56 32.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.84 -55.1 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 21' ' ' ALA . 2.8 t -46.31 -75.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.9 t80 -27.85 -40.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.767 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -66.24 -59.94 3.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.25 -47.2 12.84 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.785 0.803 . . . . 0.0 109.592 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 49.3 mt-10 -58.0 -42.76 85.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.8 -0.562 . . . . 0.0 110.409 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -54.84 -58.74 3.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 ' HB ' ' A' ' 31' ' ' ILE . 2.2 mp -74.97 -37.26 40.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.0 -8.69 54.68 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -97.34 -53.2 3.54 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.282 -1.128 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.454 ' HE1' ' O ' ' A' ' 31' ' ' ILE . 23.6 ptp -63.08 -26.81 69.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 54.3 t -89.2 26.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.8 -62.68 1.41 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.9 t -48.57 -75.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -28.07 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.759 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . 33.4 t80 -66.46 -60.33 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.32 -49.37 12.86 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.737 0.779 . . . . 0.0 109.421 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 56.9 mt-10 -58.79 -40.82 85.16 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.228 0.537 . . . . 0.0 110.324 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.603 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.216 0.532 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.9 mm -46.56 -41.59 4.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.203 -0.936 . . . . 0.0 109.478 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 32' ' ' ILE . 14.2 mm -66.19 -39.06 83.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.805 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.76 -12.54 42.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.11 -66.15 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -1.19 . . . . 0.0 109.647 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -48.75 73.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 110.107 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 78.1 t -86.47 29.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.163 -0.961 . . . . 0.0 110.062 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.72 -50.45 57.41 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.8 t -51.96 -76.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.91 -42.06 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.84 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -63.56 -60.96 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.69 -45.5 9.79 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.854 0.835 . . . . 0.0 109.716 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 92.4 mt-10 -58.47 -42.45 87.51 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.787 -0.571 . . . . 0.0 109.849 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.114 -0.991 . . . . 0.0 109.859 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.176 0.512 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mt -50.84 -37.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.142 -0.974 . . . . 0.0 110.108 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mm -73.25 -36.31 49.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.142 -0.974 . . . . 0.0 109.388 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.04 6.13 57.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -107.54 -49.6 3.22 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -1.179 . . . . 0.0 109.728 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.467 ' HE1' HG22 ' A' ' 36' ' ' VAL . 24.1 ptt? -47.37 -31.73 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.438 -0.789 . . . . 0.0 110.031 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 77.1 t -87.73 34.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.125 0.488 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -72.03 -57.06 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.9 t -48.78 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -26.51 -41.76 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.782 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.0 t80 -65.53 -60.9 2.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.12 -48.35 12.1 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 59.4 mt-10 -59.44 -40.5 86.97 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.903 -0.498 . . . . 0.0 110.323 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.586 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -82.97 -4.45 8.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.505 ' C ' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -76.87 -37.64 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.307 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.487 ' N ' HD13 ' A' ' 32' ' ' ILE . . . -77.57 3.31 60.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.1 mt -112.0 -45.71 3.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.573 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.1 ptm -52.39 -21.73 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.931 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 96.7 t -84.9 28.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.253 0.549 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -62.94 -55.52 25.24 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.2 t -49.76 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.17 -41.87 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.4 t80 -65.3 -59.79 3.67 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.58 -44.85 9.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.864 0.84 . . . . 0.0 109.419 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.84 -43.28 90.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.218 0.532 . . . . 0.0 109.992 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.714 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.424 0.63 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.18 -39.32 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.47 -0.769 . . . . 0.0 109.21 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.489 HG22 HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -79.68 -40.44 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.357 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 32' ' ' ILE . . . -68.7 -4.97 42.72 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.5 tp -89.02 -48.87 7.12 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.211 . . . . 0.0 109.395 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.1 -11.67 57.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.738 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 73.0 t -84.19 26.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 110.369 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.539 HD21 ' N ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -52.96 -57.89 8.79 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.2 t -46.92 -75.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -29.09 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.69 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -65.67 -59.98 3.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.42 -45.38 12.78 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.833 0.825 . . . . 0.0 109.699 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.67 -41.52 86.33 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.751 -0.593 . . . . 0.0 110.122 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 109.94 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.207 0.527 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.86 -58.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -74.94 -40.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.15 -8.03 41.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.4 tp -98.34 -51.34 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.213 -1.169 . . . . 0.0 109.402 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 32' ' ' ILE . 12.1 ptp -57.83 -21.22 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.489 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 53.0 t -86.15 25.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.86 -56.35 9.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.8 t -49.36 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.51 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.799 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 21.8 t80 -64.55 -61.25 2.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.78 -48.02 8.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.795 0.807 . . . . 0.0 109.454 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 78.8 mt-10 -58.22 -42.31 86.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.213 0.53 . . . . 0.0 110.032 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.894 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.416 ' O ' HG21 ' A' ' 31' ' ' ILE . 1.7 mp -81.64 -25.65 9.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.111 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -70.24 -47.29 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.263 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -66.45 -8.22 44.28 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.8 tp -93.53 -47.38 6.87 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.302 -1.116 . . . . 0.0 109.633 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 2.8 ptt? -47.17 -29.73 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.074 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 94.0 t -85.97 31.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.276 -0.89 . . . . 0.0 110.029 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -76.22 -60.66 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.4 t -49.7 -75.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -27.32 -40.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.759 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.2 t80 -65.06 -60.68 2.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -49.94 11.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.749 0.785 . . . . 0.0 109.492 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 58.9 mt-10 -58.62 -38.56 78.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.745 -0.597 . . . . 0.0 109.994 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.73 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -70.69 -45.06 75.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.228 -0.92 . . . . 0.0 108.586 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -48.08 -61.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 109.516 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -39.61 -36.87 0.76 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 38.9 mt -55.27 -56.64 17.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.36 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 6.3 ptp -66.43 -21.27 66.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.504 -0.748 . . . . 0.0 109.495 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.84 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.28 0.562 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.596 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -74.58 -58.66 3.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.0 t -48.75 -76.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' VAL . 2.3 t80 -25.88 -42.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.784 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.9 t80 -64.62 -61.76 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.91 -47.51 8.38 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.65 0.738 . . . . 0.0 109.641 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -58.3 -43.39 88.06 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.762 -0.586 . . . . 0.0 110.072 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.833 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.6 mp -85.93 -28.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 108.737 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.05 -48.51 17.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.38 -8.42 50.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.3 tp -90.37 -50.44 5.96 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.359 -1.083 . . . . 0.0 109.373 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.434 ' CG ' ' N ' ' A' ' 36' ' ' VAL . 4.9 ptm -64.6 -38.78 92.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.51 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.576 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 41.8 t -87.45 17.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.141 -0.974 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.705 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.341 0.591 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.73 -57.93 3.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.1 t -51.2 -76.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.5 t80 -25.83 -42.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.778 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 18' ' ' VAL . 6.1 t80 -63.4 -62.55 1.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.63 -47.45 7.58 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.735 0.779 . . . . 0.0 109.823 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 67.4 mt-10 -58.62 -43.03 89.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.706 -0.621 . . . . 0.0 110.357 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 109.999 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.33 -22.24 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 3.9 pt -77.74 -45.08 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.305 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -61.7 -13.59 39.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.4 mt -74.01 -49.48 24.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -1.185 . . . . 0.0 109.556 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.6 ptm -62.75 -35.02 78.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.543 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 55.0 t -93.82 24.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.177 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -73.11 -59.73 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.0 t -48.85 -75.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.57 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.669 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.1 t80 -63.72 -62.17 1.83 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.2 -47.26 9.21 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.796 0.807 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -58.82 -41.59 87.22 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.137 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.076 -1.015 . . . . 0.0 110.06 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -20.34 26.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.053 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mm -76.62 -45.05 33.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.41 -0.806 . . . . 0.0 109.567 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.15 -34.76 87.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -71.03 -55.67 7.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -1.11 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.455 ' HG3' HG21 ' A' ' 36' ' ' VAL . 3.9 ptt? -58.95 -26.73 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 109.689 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 69.0 t -88.82 25.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.195 0.522 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.612 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.35 -59.37 3.46 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.2 t -49.09 -76.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.2 t80 -26.95 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.731 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.1 t80 -65.77 -60.77 2.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.49 -48.73 10.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.789 0.804 . . . . 0.0 109.444 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -56.57 -47.69 78.95 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.788 -0.57 . . . . 0.0 110.015 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.215 0.531 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -29.42 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.117 -0.989 . . . . 0.0 109.557 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -74.69 -47.24 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -70.73 -3.83 51.24 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.3 tp -98.71 -53.28 3.35 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.168 -1.196 . . . . 0.0 109.34 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.1 ptm -48.38 -22.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 80.7 t -87.19 31.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.337 -0.852 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.652 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.93 -56.49 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.0 t -49.04 -76.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.522 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.59 -41.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.7 t80 -64.98 -61.48 2.13 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -42.68 -47.47 5.35 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.901 0.858 . . . . 0.0 109.317 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.4 mt-10 -56.64 -45.37 81.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.193 0.521 . . . . 0.0 109.912 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.328 0.585 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.69 -30.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 8.9 pt -80.81 -47.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 108.838 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.56 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.74 -21.46 9.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' VAL . 27.2 mt -80.94 -67.15 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -43.76 -25.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.668 -0.645 . . . . 0.0 110.045 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 89.8 t -86.73 31.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -0.917 . . . . 0.0 109.893 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 5.3 mmmt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -71.4 -54.45 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.3 t -55.84 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.534 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.8 -42.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.981 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.6 t80 -64.11 -61.23 2.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.92 -46.92 8.32 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.819 0.818 . . . . 0.0 109.43 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.16 -43.3 87.35 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.83 -0.544 . . . . 0.0 109.707 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.254 0.549 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -42.26 -34.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.9 pt -71.15 -47.76 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.038 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.581 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -49.7 -24.8 6.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 34.6 mt -62.32 -61.69 2.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -1.002 . . . . 0.0 109.4 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 18.9 ptt? -60.63 -18.36 52.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.746 -0.596 . . . . 0.0 109.741 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 95.7 t -87.08 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.21 -0.932 . . . . 0.0 110.073 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.728 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.92 -59.38 3.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.1 t -48.07 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.53 ' C ' ' O ' ' A' ' 18' ' ' VAL . 42.1 t80 -26.47 -43.88 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.807 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -62.25 -60.73 3.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -46.26 -48.7 17.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.739 0.78 . . . . 0.0 109.885 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.34 -36.8 76.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.702 -0.624 . . . . 0.0 110.227 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 109.587 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.54 -18.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.287 -0.883 . . . . 0.0 109.076 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 32' ' ' ILE . 1.9 mp -87.62 -38.18 11.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.298 -0.876 . . . . 0.0 109.047 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.28 67.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.52 -54.16 3.9 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.25 -1.147 . . . . 0.0 109.235 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -63.23 -33.19 74.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 67.4 t -88.65 24.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.826 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 3.0 mmtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.399 0.619 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -75.44 -58.9 3.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.2 t -52.01 -76.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' C ' ' O ' ' A' ' 18' ' ' VAL . 3.0 t80 -27.51 -41.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.656 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.35 -61.82 2.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.57 -48.59 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.762 0.792 . . . . 0.0 109.364 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.79 -42.71 79.94 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.86 -0.525 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.201 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.73 -52.49 9.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -52.51 -39.13 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.63 0.728 . . . . 0.0 109.471 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 32' ' ' ILE . . . -62.24 -37.44 94.56 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -74.86 0.1 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.29 -1.124 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -52.86 59.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 110.482 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 9.5 t -82.65 28.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.074 -1.016 . . . . 0.0 110.953 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 33' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.99 172.81 11.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.253 -0.904 . . . . 0.0 109.587 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' PHE . 1.1 tp10 -150.55 27.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 109.379 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' GLU . 2.8 p90 -40.71 -44.99 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HG3' ' C ' ' A' ' 4' ' ' PHE . 1.9 mtp180 -133.46 -144.11 0.22 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 67.69 22.09 9.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -121.38 106.86 11.83 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.379 -0.826 . . . . 0.0 109.437 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.407 ' C ' ' OE2' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -156.05 -144.66 0.14 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 108.981 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.72 -57.75 0.19 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 8.3 t80 -62.33 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -1.096 . . . . 0.0 108.799 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.547 ' HA ' ' CG ' ' A' ' 15' ' ' GLN . 3.9 mt-10 77.89 7.45 2.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.854 -1.154 . . . . 0.0 110.739 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -96.11 -17.83 6.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.91 -1.119 . . . . 0.0 109.519 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -141.54 -49.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.502 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.443 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -47.32 -30.79 3.38 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.682 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.547 ' CG ' ' HA ' ' A' ' 11' ' ' GLU . 32.2 mm-40 -66.2 -52.07 51.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.638 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -51.67 -23.6 4.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 109.18 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -78.11 -59.68 2.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.8 t -50.25 -75.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.94 -42.16 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.582 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.4 t80 -62.6 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.1 -47.49 6.08 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.599 0.714 . . . . 0.0 109.673 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' OE2' ' CG1' ' A' ' 18' ' ' VAL . 51.0 mt-10 -56.47 -46.91 80.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.653 -0.654 . . . . 0.0 109.969 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.28 14.63 19.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 20' ' ' PHE . 8.0 t -92.51 -78.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 123.26 -47.35 1.03 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER 164.79 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -1.143 . . . . 0.0 109.642 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -126.1 -138.7 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.905 . . . . 0.0 109.123 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -103.68 160.8 14.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.4 -91.15 0.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.53 -87.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.304 -1.116 . . . . 0.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -27.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.379 -0.826 . . . . 0.0 109.407 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.567 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.8 pt -59.44 -46.86 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.82 -25.11 21.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 mt -79.49 -67.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -1.194 . . . . 0.0 109.773 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.5 ptp -50.37 -21.08 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.61 -0.681 . . . . 0.0 109.703 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.544 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 91.7 t -88.45 28.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.97 45.96 0.52 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.24 -73.19 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.09 -32.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 11.0 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.523 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.408 0.623 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.23 144.14 28.31 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.683 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -112.43 94.21 4.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 109.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -49.2 3.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 109.756 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -96.16 -149.76 0.32 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 109.085 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' ARG . 3.6 t60 41.72 27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.762 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' ARG . 1.1 t0 -154.49 -150.81 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.1 p -118.6 -144.37 0.37 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.204 -0.935 . . . . 0.0 109.191 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 14' ' ' HIS . . . -121.29 -52.69 0.23 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 1.4 t80 -156.21 -119.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.079 . . . . 0.0 109.231 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 9.7 mt-10 -168.2 -59.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 0.0 109.243 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.1 t -82.81 -34.39 11.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.19 -0.944 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -118.67 60.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.574 ' CE1' ' HA3' ' A' ' 9' ' ' GLY . 7.3 t60 -172.17 -41.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.093 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 32.3 mm-40 -77.45 -32.91 54.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 108.796 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -85.24 -32.02 22.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.618 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.85 -52.1 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.3 t -52.18 -76.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.33 -42.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.62 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.0 t80 -63.0 -61.63 2.26 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.01 -46.4 8.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.674 0.749 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.9 mt-10 -57.73 -43.11 85.09 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.826 -0.546 . . . . 0.0 109.934 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.36 15.92 19.91 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 3.8 t -90.0 -59.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.79 49.59 3.55 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m 46.39 58.78 4.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' HB2' HG11 ' A' ' 24' ' ' VAL . 1.4 t-20 -84.96 12.97 6.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -177.01 -176.68 0.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 32' ' ' ILE . . . -161.96 58.31 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.69 -57.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -1.19 . . . . 0.0 109.634 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 31' ' ' ILE . 2.7 mp -54.53 -19.87 4.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.219 -0.926 . . . . 0.0 109.887 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.431 HD11 ' HA2' ' A' ' 29' ' ' GLY . 14.5 mt -64.71 -45.91 93.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.229 -0.919 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -44.64 -31.4 2.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -65.54 -77.55 0.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.437 -1.037 . . . . 0.0 109.928 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.492 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 1.8 ptt? -40.53 -26.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.814 -0.554 . . . . 0.0 110.285 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 78.3 t -84.15 30.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 110.208 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.56 -65.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 110.46 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.38 -17.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.515 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.306 0.574 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 170.87 14.17 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.566 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.13 99.34 4.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -125.4 -59.38 1.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.825 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 76.46 7.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.753 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.8 111.49 6.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -52.13 168.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -109.25 28.41 8.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.33 70.36 0.23 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 14' ' ' HIS . 5.5 t80 -74.27 -129.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 108.887 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 51.79 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.765 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' TYR . 3.4 t -47.35 -23.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 110.209 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -97.61 48.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 109.691 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 43.3 t60 179.64 -61.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.463 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 38.3 mm-40 -56.57 -54.59 44.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.304 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 15' ' ' GLN . 2.5 mmmt -42.35 -27.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.53 -64.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -50.04 -71.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.542 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.11 -41.88 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.443 179.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.587 ' N ' ' O ' ' A' ' 18' ' ' VAL . 16.3 t80 -66.01 -63.67 1.03 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -49.22 -49.31 43.62 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.595 0.712 . . . . 0.0 110.192 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.08 -37.21 74.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.755 -0.591 . . . . 0.0 109.991 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 16.56 23.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 20' ' ' PHE . 8.2 t -92.28 -45.31 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.61 -41.95 2.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.08 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -1.066 . . . . 0.0 109.322 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' N ' HG13 ' A' ' 24' ' ' VAL . 1.3 m-20 -65.32 86.24 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.473 -0.767 . . . . 0.0 109.395 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -52.71 -70.14 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.457 -0.777 . . . . 0.0 109.473 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.69 75.09 0.68 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.07 -61.23 1.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -1.101 . . . . 0.0 109.931 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.7 mp -96.92 -22.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -93.13 -38.05 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' N ' HD13 ' A' ' 32' ' ' ILE . . . -76.4 1.66 60.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 33' ' ' GLY . 36.0 mt -122.24 -49.87 2.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.444 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 18.4 ptm -54.58 -38.16 66.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.76 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 78.5 t -86.76 30.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 34.12 4.13 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.45 -129.9 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.04 29.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -1.115 . . . . 0.0 109.443 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.507 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.7 32.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.193 -0.942 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -107.26 93.64 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 5' ' ' ARG . 0.9 OUTLIER -124.26 -174.19 2.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.858 . . . . 0.0 109.63 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' PHE . 2.0 mpt_? 61.92 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.91 166.17 16.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.628 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -145.12 137.47 25.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.0 109.326 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -75.74 81.24 2.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.594 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.18 84.77 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.456 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -105.35 -74.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.2 -1.177 . . . . 0.0 108.934 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 2.2 mt-10 64.49 -97.83 0.06 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.426 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 t -45.16 -24.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.682 -1.261 . . . . 0.0 109.742 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -100.4 47.58 0.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.505 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER 177.39 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.934 -1.104 . . . . 0.0 110.216 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 32.4 mm-40 -71.96 -57.7 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -58.35 -37.95 76.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.757 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -63.4 -55.66 22.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.4 t -50.76 -76.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.538 ' C ' ' O ' ' A' ' 18' ' ' VAL . 2.7 t80 -27.24 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.794 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 18' ' ' VAL . 12.6 t80 -63.68 -61.11 2.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -48.51 12.03 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.74 0.781 . . . . 0.0 109.618 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 55.8 mt-10 -58.37 -39.51 79.81 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.646 -0.659 . . . . 0.0 109.898 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.68 15.84 26.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.752 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 25' ' ' GLY . 2.5 t -101.91 -61.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 24' ' ' VAL . . . 96.93 43.88 2.97 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 48.64 49.8 18.1 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.441 -1.035 . . . . 0.0 109.419 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -57.18 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.384 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 66.74 79.97 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.76 29.33 0.75 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.02 -63.05 1.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -1.073 . . . . 0.0 109.533 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.56 -33.75 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.27 -0.893 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 4.9 pt -64.68 -48.51 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 108.836 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -54.56 -29.47 48.22 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.49 -70.13 0.16 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.519 -0.989 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.8 ptt? -48.58 -31.46 6.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.743 -0.598 . . . . 0.0 109.807 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 36' ' ' VAL . 42.8 t -86.56 32.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.78 18.18 22.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.82 70.48 0.52 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.49 26.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -1.145 . . . . 0.0 109.527 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.352 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.8 -178.65 1.24 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -148.53 25.28 0.97 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -124.48 176.96 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' A' ' 6' ' ' HIS . 3.4 mpt_? 66.28 76.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.481 ' CB ' ' O ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER 73.54 -167.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -148.13 -44.15 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.13 121.64 0.1 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.43 -68.47 1.65 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 17.1 t80 -120.85 -118.26 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -1.117 . . . . 0.0 109.157 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 7.4 mt-10 -164.87 -95.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.737 -1.227 . . . . 0.0 109.898 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 t -50.83 -39.82 19.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.938 -1.101 . . . . 0.0 110.455 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 94.8 m-70 -109.82 68.89 0.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 110.237 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.507 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 5.3 t-80 177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.04 . . . . 0.0 110.277 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 38.9 mm-40 -57.18 -16.64 8.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 0.0 110.142 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -88.2 -32.49 18.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.053 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.84 -55.1 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 21' ' ' ALA . 2.8 t -46.31 -75.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.9 t80 -27.85 -40.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.767 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -66.24 -59.94 3.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.25 -47.2 12.84 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.785 0.803 . . . . 0.0 109.592 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 49.3 mt-10 -58.0 -42.76 85.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.8 -0.562 . . . . 0.0 110.409 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.97 16.27 14.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 4.5 t -95.5 -57.6 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.81 39.16 5.3 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.78 63.23 2.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.442 -1.034 . . . . 0.0 109.585 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.457 ' HB2' HG11 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -74.29 -76.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.534 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -119.71 119.94 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.568 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.21 27.66 0.62 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.48 -68.92 0.88 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -54.84 -58.74 3.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 ' HB ' ' A' ' 31' ' ' ILE . 2.2 mp -74.97 -37.26 40.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.0 -8.69 54.68 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -97.34 -53.2 3.54 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.282 -1.128 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.454 ' HE1' ' O ' ' A' ' 31' ' ' ILE . 23.6 ptp -63.08 -26.81 69.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 54.3 t -89.2 26.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 158.66 84.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.72 50.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.57 11.11 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.394 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.481 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.32 128.86 33.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.69 25.83 10.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.544 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -137.19 -50.04 0.63 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 110.035 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.72 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 110.082 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -179.52 101.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.763 . . . . 0.0 109.506 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.77 128.98 9.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.504 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.81 108.63 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 0.0 109.573 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.82 71.3 0.08 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB3' ' CB ' ' A' ' 14' ' ' HIS . 20.2 t80 -118.85 -102.52 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -1.168 . . . . 0.0 109.748 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 16.0 mt-10 -162.6 -168.33 1.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.23 . . . . 0.0 111.139 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.2 t -34.19 -34.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.218 0.532 . . . . 0.0 110.538 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -87.45 40.76 0.94 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.015 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . 76.5 t60 -159.09 -45.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.931 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.511 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 13.8 mm-40 -69.43 -48.63 60.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -58.85 -24.65 62.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 109.645 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.8 -62.68 1.41 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.9 t -48.57 -75.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -28.07 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.759 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . 33.4 t80 -66.46 -60.33 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.32 -49.37 12.86 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.737 0.779 . . . . 0.0 109.421 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 56.9 mt-10 -58.79 -40.82 85.16 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.228 0.537 . . . . 0.0 110.324 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.06 17.02 16.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.603 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 3.7 t -103.03 157.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -138.99 -47.03 0.06 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.84 35.07 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.321 -1.106 . . . . 0.0 109.197 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -45.32 -64.62 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -127.57 -33.06 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.581 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.52 88.57 1.76 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.13 -64.11 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.708 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.9 mm -46.56 -41.59 4.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.203 -0.936 . . . . 0.0 109.478 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 32' ' ' ILE . 14.2 mm -66.19 -39.06 83.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.805 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.76 -12.54 42.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.11 -66.15 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -1.19 . . . . 0.0 109.647 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -48.75 73.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 110.107 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 78.1 t -86.47 29.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.163 -0.961 . . . . 0.0 110.062 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -135.51 57.64 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.82 33.74 2.43 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.42 6.97 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.436 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.04 167.26 0.17 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.176 -0.952 . . . . 0.0 109.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -119.81 98.05 5.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 5' ' ' ARG . 12.1 p90 -161.46 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.659 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -108.87 90.24 3.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.51 -153.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 108.984 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -47.09 165.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.047 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -102.99 -142.44 0.36 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.347 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.09 -74.05 0.26 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 4.9 t80 -111.85 -93.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.04 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.637 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 9.9 mt-10 -156.26 -168.91 2.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.906 -1.121 . . . . 0.0 110.389 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.4 t -40.63 -29.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 O-C-N 121.597 -0.689 . . . . 0.0 109.832 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -88.77 40.07 0.95 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 55.8 t-80 -158.05 -44.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.502 ' NE2' ' C ' ' A' ' 11' ' ' GLU . 2.7 mt-30 -81.63 -60.1 2.37 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.411 -0.805 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -47.43 -26.12 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.085 -1.009 . . . . 0.0 109.091 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.72 -50.45 57.41 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.8 t -51.96 -76.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.91 -42.06 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.84 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -63.56 -60.96 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.69 -45.5 9.79 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.854 0.835 . . . . 0.0 109.716 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 92.4 mt-10 -58.47 -42.45 87.51 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.787 -0.571 . . . . 0.0 109.849 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.16 16.03 17.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.114 -0.991 . . . . 0.0 109.859 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 5.6 t -91.14 164.88 2.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -82.4 -58.09 2.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.61 54.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -1.225 . . . . 0.0 109.586 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -97.09 -59.13 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.499 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' CG ' HG23 ' A' ' 32' ' ' ILE . 5.6 tttm -139.2 97.96 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.94 -86.49 1.21 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.99 -70.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.054 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mt -50.84 -37.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.142 -0.974 . . . . 0.0 110.108 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG23 ' CG ' ' A' ' 28' ' ' LYS . 8.2 mm -73.25 -36.31 49.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.142 -0.974 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.04 6.13 57.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -107.54 -49.6 3.22 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -1.179 . . . . 0.0 109.728 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.467 ' HE1' HG22 ' A' ' 36' ' ' VAL . 24.1 ptt? -47.37 -31.73 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.438 -0.789 . . . . 0.0 110.031 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 77.1 t -87.73 34.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.47 -61.16 2.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 39' ' ' VAL . . . 106.3 26.85 5.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 38' ' ' GLY . 15.1 m 40.67 37.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.971 . . . . 0.0 109.768 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 39' ' ' VAL . 8.6 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.81 -1.091 . . . . 0.0 109.443 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.36 176.04 5.65 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.216 -0.927 . . . . 0.0 109.709 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.28 95.1 4.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.461 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.558 ' CE2' ' HG3' ' A' ' 5' ' ' ARG . 31.4 p90 -157.59 -36.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.558 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 22.9 mtt180 -60.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.425 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -115.39 146.11 41.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -112.57 -61.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 4.7 t 72.64 58.28 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.47 74.49 0.02 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.0 t80 -90.45 -99.64 0.1 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 36.8 mt-10 -157.81 -154.11 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.939 -1.101 . . . . 0.0 110.228 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.4 t -38.4 -35.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 110.381 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -86.2 40.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 109.183 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 9.4 t60 -164.81 -42.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.435 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 25.4 mm-40 -68.92 -51.21 42.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.517 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -58.24 -27.94 64.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.722 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -72.03 -57.06 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.9 t -48.78 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -26.51 -41.76 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.782 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.0 t80 -65.53 -60.9 2.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.12 -48.35 12.1 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 59.4 mt-10 -59.44 -40.5 86.97 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.903 -0.498 . . . . 0.0 110.323 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.42 15.49 15.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.586 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 3.1 t -100.51 -67.29 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.66 43.54 4.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.7 69.3 0.7 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -1.075 . . . . 0.0 109.237 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 1.5 t30 -81.76 78.63 8.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 1.7 ptpt 41.15 30.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 0.0 110.194 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 81.82 1.25 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.34 -67.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -82.97 -4.45 8.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.505 ' C ' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -76.87 -37.64 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.307 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' N ' HD13 ' A' ' 32' ' ' ILE . . . -77.57 3.31 60.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.1 mt -112.0 -45.71 3.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.573 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.1 ptm -52.39 -21.73 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.931 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 96.7 t -84.9 28.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.38 73.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.31 113.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -74.87 -38.64 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.226 -1.161 . . . . 0.0 109.092 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 39' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.313 0.577 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.02 171.25 12.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -123.29 98.69 5.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -128.31 -39.59 1.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.521 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -50.19 88.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.632 -0.667 . . . . 0.0 109.625 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.2 t-160 -125.17 23.64 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.89 -163.37 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 76.7 p -156.0 100.43 2.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.94 60.17 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -168.44 -131.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.105 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 27.7 mt-10 79.23 6.86 2.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.98 -11.99 8.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.12 -45.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.865 . . . . 0.0 109.887 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.474 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 t-160 -57.76 -23.37 51.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.244 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 11' ' ' GLU . 51.1 mm-40 -60.36 -33.74 72.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.073 -1.017 . . . . 0.0 110.307 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -72.21 -39.36 68.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.855 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -62.94 -55.52 25.24 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.2 t -49.76 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.17 -41.87 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.4 t80 -65.3 -59.79 3.67 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.58 -44.85 9.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.864 0.84 . . . . 0.0 109.419 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.84 -43.28 90.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.218 0.532 . . . . 0.0 109.992 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.98 16.22 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.714 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 4.5 t -96.8 160.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -89.53 -41.43 5.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.15 71.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -1.152 . . . . 0.0 109.445 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.53 6.09 25.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt 52.14 -173.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.08 50.75 0.88 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.88 -50.55 2.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.18 -39.32 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.47 -0.769 . . . . 0.0 109.21 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.489 HG22 HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -79.68 -40.44 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.357 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 32' ' ' ILE . . . -68.7 -4.97 42.72 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD13 ' HA3' ' A' ' 38' ' ' GLY . 33.5 tp -89.02 -48.87 7.12 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.211 . . . . 0.0 109.395 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.1 -11.67 57.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.738 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 73.0 t -84.19 26.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 110.369 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.55 67.05 0.53 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -152.64 71.92 0.28 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 m -137.62 -43.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -1.091 . . . . 0.0 109.479 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.392 179.864 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.277 0.561 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.44 171.46 0.19 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.246 -0.909 . . . . 0.0 109.558 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.92 105.48 8.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.6 p90 -147.32 176.74 9.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.3 101.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 6' ' ' HIS . 1.3 p-80 -117.83 162.5 18.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.602 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -146.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.18 -142.92 0.35 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.207 -0.933 . . . . 0.0 109.165 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.493 ' HA3' ' CD2' ' A' ' 14' ' ' HIS . . . -113.68 -70.21 0.53 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 6.7 t80 -179.75 -108.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 2.3 mt-10 -169.43 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.8 -1.187 . . . . 0.0 110.212 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.6 -39.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.904 -1.123 . . . . 0.0 110.11 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.03 58.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.493 ' CD2' ' HA3' ' A' ' 9' ' ' GLY . 1.8 t60 -175.0 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 41.0 mm-40 -62.77 -35.87 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.36 -0.837 . . . . 0.0 109.052 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.74 -42.44 77.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.394 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.539 ' N ' HD21 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -52.96 -57.89 8.79 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.2 t -46.92 -75.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -29.09 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.69 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -65.67 -59.98 3.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.42 -45.38 12.78 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.833 0.825 . . . . 0.0 109.699 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.67 -41.52 86.33 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.751 -0.593 . . . . 0.0 110.122 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.21 15.63 18.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 109.94 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 5.1 t -89.44 -47.66 14.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 90.84 30.26 11.75 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 69.04 68.56 0.27 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.575 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -143.15 59.3 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.394 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -113.72 128.84 56.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . . . 156.78 85.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.35 -57.55 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.645 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.86 -58.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -74.94 -40.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA3' ' CA ' ' A' ' 29' ' ' GLY . . . -66.15 -8.03 41.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.4 tp -98.34 -51.34 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.213 -1.169 . . . . 0.0 109.402 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 32' ' ' ILE . 12.1 ptp -57.83 -21.22 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.489 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.578 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 53.0 t -86.15 25.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 21.88 28.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.42 7.83 64.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -115.7 0.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -1.182 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.915 -1.04 . . . . 0.0 109.374 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.34 158.47 24.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -126.95 94.77 4.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.54 ' CE2' ' HD3' ' A' ' 5' ' ' ARG . 9.2 p90 -171.38 -159.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.751 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.54 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 65.23 104.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.677 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -157.54 171.33 20.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.427 -0.795 . . . . 0.0 109.133 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.41 -73.01 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.502 ' HA ' ' NE2' ' A' ' 14' ' ' HIS . 45.6 t 47.47 64.62 1.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.447 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.4 41.09 0.1 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.556 ' HB3' ' CB ' ' A' ' 14' ' ' HIS . 8.6 t80 -106.54 -102.14 0.34 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -1.221 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' HG3' ' CD1' ' A' ' 10' ' ' TYR . 57.9 mt-10 -157.44 -166.94 2.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.72 -1.238 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.6 t -39.33 -34.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.764 -0.585 . . . . 0.0 110.043 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -85.64 39.63 0.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 108.752 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . 9.4 t60 -158.42 -42.76 0.06 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.466 -0.771 . . . . 0.0 109.589 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 25.5 mm-40 -65.39 -9.71 27.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -98.43 -35.7 10.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.349 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.86 -56.35 9.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.8 t -49.36 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.51 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.799 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 21.8 t80 -64.55 -61.25 2.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.78 -48.02 8.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.795 0.807 . . . . 0.0 109.454 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 78.8 mt-10 -58.22 -42.31 86.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.213 0.53 . . . . 0.0 110.032 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.2 17.35 17.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.894 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 6.4 t -90.51 159.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -94.16 -53.29 1.76 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -168.96 63.45 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -1.125 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.32 65.31 9.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.613 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -51.08 163.37 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.24 76.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.03 -54.42 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -1.095 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.416 ' O ' HG21 ' A' ' 31' ' ' ILE . 1.7 mp -81.64 -25.65 9.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.111 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -70.24 -47.29 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.263 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -66.45 -8.22 44.28 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.8 tp -93.53 -47.38 6.87 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.302 -1.116 . . . . 0.0 109.633 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 2.8 ptt? -47.17 -29.73 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.074 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.538 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 94.0 t -85.97 31.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.276 -0.89 . . . . 0.0 110.029 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.05 10.59 5.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.82 85.27 0.36 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 40' ' ' VAL . 29.3 m -130.0 32.34 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.219 -1.165 . . . . 0.0 109.392 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 39' ' ' VAL . 15.0 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.367 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.63 130.88 14.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -131.99 24.71 4.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.708 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 45.9 p90 -70.99 156.31 39.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.067 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' PHE . 1.7 mpt_? 68.27 116.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 109.114 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -43.47 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.99 -149.96 0.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -149.48 116.28 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.181 -0.949 . . . . 0.0 109.3 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 8' ' ' SER . . . -43.82 -50.79 7.18 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.1 t80 -150.38 -128.48 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.161 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.544 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 15.2 mt-10 -167.65 -37.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.826 -1.171 . . . . 0.0 109.787 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.53 -37.79 7.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.155 -0.965 . . . . 0.0 109.838 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' HIS . 31.5 m170 -101.78 -49.39 3.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.074 -1.016 . . . . 0.0 110.059 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 11.8 t-160 -42.92 -29.95 0.37 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.967 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 30.6 mm-40 -66.45 -54.85 19.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.633 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -47.15 -26.58 1.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.372 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -76.22 -60.66 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 20' ' ' PHE . 2.4 t -49.7 -75.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.535 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -27.32 -40.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.759 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.2 t80 -65.06 -60.68 2.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -49.94 11.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.749 0.785 . . . . 0.0 109.492 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 58.9 mt-10 -58.62 -38.56 78.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.745 -0.597 . . . . 0.0 109.994 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.12 16.77 25.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.73 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 20' ' ' PHE . 5.0 t -90.08 -71.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.44 -48.88 0.73 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.84 46.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -1.195 . . . . 0.0 109.772 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 33.1 t30 -46.7 -75.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 109.128 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 76.58 133.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 109.77 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.4 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.04 -88.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -1.091 . . . . 0.0 109.32 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -70.69 -45.06 75.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.228 -0.92 . . . . 0.0 108.586 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -48.08 -61.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 109.516 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -39.61 -36.87 0.76 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 38.9 mt -55.27 -56.64 17.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.36 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 6.3 ptp -66.43 -21.27 66.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.504 -0.748 . . . . 0.0 109.495 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.84 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.24 -79.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.79 49.53 28.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -102.27 18.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.497 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.7 179.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.064 -1.023 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -178.82 30.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.704 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.596 ' CD2' ' HB2' ' A' ' 5' ' ' ARG . 37.2 p90 -96.78 -43.13 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.545 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.596 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -116.2 -148.97 0.44 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.152 -0.967 . . . . 0.0 109.049 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 0.0 109.557 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -120.46 -86.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.371 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -178.01 109.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.93 -89.1 1.32 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 4.4 t80 -131.65 -135.24 0.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.182 . . . . 0.0 109.3 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 21.8 mt-10 -164.02 -38.38 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.892 -1.13 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -93.23 -14.06 8.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.192 -0.943 . . . . 0.0 109.846 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 14' ' ' HIS . 1.2 t60 -129.45 -57.71 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 109.768 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' HIS . 18.6 t-80 -42.89 -29.7 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 39.1 mm-40 -73.34 -50.85 19.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.787 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -55.91 -23.78 33.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.596 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -74.58 -58.66 3.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.0 t -48.75 -76.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' VAL . 2.3 t80 -25.88 -42.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.784 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.9 t80 -64.62 -61.76 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.91 -47.51 8.38 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.65 0.738 . . . . 0.0 109.641 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -58.3 -43.39 88.06 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.762 -0.586 . . . . 0.0 110.072 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.47 16.4 10.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.833 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 3.7 t -106.51 -82.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . 119.83 -46.56 1.11 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER 167.13 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -1.138 . . . . 0.0 109.303 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -75.82 -65.35 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 151.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.408 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.28 47.88 27.37 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.97 -61.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -1.161 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.6 mp -85.93 -28.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 108.737 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.05 -48.51 17.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.38 -8.42 50.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.3 tp -90.37 -50.44 5.96 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.359 -1.083 . . . . 0.0 109.373 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.434 ' CG ' ' N ' ' A' ' 36' ' ' VAL . 4.9 ptm -64.6 -38.78 92.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.51 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.576 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 41.8 t -87.45 17.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.141 -0.974 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.72 31.24 4.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.68 97.36 0.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 40' ' ' VAL . 4.2 m -94.8 -37.72 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -1.135 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG11 ' OXT' ' A' ' 40' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.27 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB2' ' CD ' ' A' ' 5' ' ' ARG . . . -81.85 117.65 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.16 7.58 17.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.676 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 5' ' ' ARG . 22.7 p90 -91.55 -32.49 15.52 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.732 -0.605 . . . . 0.0 109.719 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.6 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.16 78.08 9.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -115.36 139.46 49.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.5 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.52 -159.11 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 109.553 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 t -124.32 59.1 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.07 -68.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 14' ' ' HIS . 1.6 t80 -157.38 -143.83 0.12 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -1.152 . . . . 0.0 109.256 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 29.1 mt-10 69.77 0.62 3.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.7 -17.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.884 -1.135 . . . . 0.0 109.299 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -130.64 54.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -170.26 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -72.38 -31.33 65.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -74.29 -25.7 59.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.487 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.73 -57.93 3.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.1 t -51.2 -76.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.5 t80 -25.83 -42.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.778 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 18' ' ' VAL . 6.1 t80 -63.4 -62.55 1.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.63 -47.45 7.58 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.735 0.779 . . . . 0.0 109.823 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 67.4 mt-10 -58.62 -43.03 89.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.706 -0.621 . . . . 0.0 110.357 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.06 15.11 6.4 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 109.999 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 2.9 t -116.79 159.09 17.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -102.49 -38.35 3.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.74 65.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -1.145 . . . . 0.0 109.234 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -51.79 -92.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.592 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -178.74 -77.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.41 64.5 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.8 -54.89 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.243 . . . . 0.0 109.391 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.33 -22.24 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 3.9 pt -77.74 -45.08 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.305 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -61.7 -13.59 39.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.4 mt -74.01 -49.48 24.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -1.185 . . . . 0.0 109.556 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.6 ptm -62.75 -35.02 78.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.543 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 55.0 t -93.82 24.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.177 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.89 -45.97 11.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.53 -129.17 2.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 40' ' ' VAL . 14.4 m -118.44 38.11 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -1.143 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 39' ' ' VAL . 5.1 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.41 119.63 14.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 3' ' ' GLU . 9.0 tt0 -94.04 27.26 2.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -140.88 -54.78 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.467 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -126.47 -154.74 0.65 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 7' ' ' ASP . 2.3 m-70 -120.25 134.91 55.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.027 -1.046 . . . . 0.0 109.836 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' HIS . 32.6 t0 37.91 -130.1 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.638 -0.664 . . . . 0.0 110.23 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.99 125.51 2.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 109.084 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.58 -55.09 28.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -117.68 -132.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.238 . . . . 0.0 110.213 -179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 28.8 mt-10 -163.89 -32.93 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.1 -26.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 121.057 -1.027 . . . . 0.0 110.603 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -114.87 -28.76 6.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.622 -1.298 . . . . 0.0 111.22 -178.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 10' ' ' TYR . 52.5 t-80 -60.54 -11.98 8.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 110.357 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.494 ' NE2' ' C ' ' A' ' 11' ' ' GLU . 2.7 mp0 -85.63 -51.38 6.51 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.492 -0.755 . . . . 0.0 109.708 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -55.3 -26.13 38.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.248 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -73.11 -59.73 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.0 t -48.85 -75.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.57 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.669 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.1 t80 -63.72 -62.17 1.83 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.2 -47.26 9.21 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.796 0.807 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -58.82 -41.59 87.22 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.137 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 13.93 23.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.076 -1.015 . . . . 0.0 110.06 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 21' ' ' ALA . 6.8 t -86.79 159.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -99.75 -52.33 1.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -171.56 58.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -1.156 . . . . 0.0 109.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -99.24 61.23 1.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -113.43 144.19 43.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.176 -0.953 . . . . 0.0 109.634 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.14 45.95 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.7 -82.61 0.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -1.147 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -20.34 26.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.053 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 mm -76.62 -45.05 33.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.41 -0.806 . . . . 0.0 109.567 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.15 -34.76 87.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.4 mt -71.03 -55.67 7.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -1.11 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.455 ' HG3' HG21 ' A' ' 36' ' ' VAL . 3.9 ptt? -58.95 -26.73 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 109.689 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.565 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 69.0 t -88.82 25.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.88 74.67 1.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.14 -25.1 14.97 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 40' ' ' VAL . 23.7 m -138.47 -46.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -1.202 . . . . 0.0 109.687 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 39' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 109.587 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.16 136.01 56.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -100.53 30.75 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -167.69 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 6' ' ' HIS . 1.5 tpt180 -72.49 -145.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.09 -1.006 . . . . 0.0 109.363 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 5' ' ' ARG . 4.7 m170 47.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -79.4 -78.92 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.661 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 56.39 50.98 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.358 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.35 70.96 1.03 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 13.5 t80 -91.78 -97.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -1.187 . . . . 0.0 109.733 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 67.7 mt-10 -157.5 -145.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.856 -1.152 . . . . 0.0 110.073 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 11' ' ' GLU . 4.4 t -37.77 -41.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.05 45.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 7' ' ' ASP . 11.6 t60 -166.12 -40.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.945 . . . . 0.0 110.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 29.2 mm-40 -67.7 -62.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -44.9 -35.93 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.612 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.35 -59.37 3.46 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.2 t -49.09 -76.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' C ' ' O ' ' A' ' 18' ' ' VAL . 4.2 t80 -26.95 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.731 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.1 t80 -65.77 -60.77 2.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.49 -48.73 10.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.789 0.804 . . . . 0.0 109.444 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -56.57 -47.69 78.95 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.788 -0.57 . . . . 0.0 110.015 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 14.51 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 3.4 t -108.32 -84.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . 128.98 -38.37 2.04 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.2 59.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -1.22 . . . . 0.0 109.963 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' HB2' HG12 ' A' ' 24' ' ' VAL . 2.4 t30 -67.45 -57.52 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 109.23 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.15 173.13 15.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.399 -0.813 . . . . 0.0 109.189 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.41 83.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.8 -58.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -1.077 . . . . 0.0 109.916 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -29.42 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.117 -0.989 . . . . 0.0 109.557 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -74.69 -47.24 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -70.73 -3.83 51.24 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.3 tp -98.71 -53.28 3.35 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.168 -1.196 . . . . 0.0 109.34 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.1 ptm -48.38 -22.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 80.7 t -87.19 31.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.337 -0.852 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.69 20.02 21.41 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.05 -12.21 3.87 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 120.999 -1.295 . . . . 0.0 109.933 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 35' ' ' MET . 1.9 m -121.18 43.6 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.101 -1.235 . . . . 0.0 109.505 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' CG2' HG23 ' A' ' 36' ' ' VAL . 13.7 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.38 132.69 35.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 4' ' ' PHE . 2.8 mt-10 -67.77 -10.73 55.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 0.0 108.557 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLU . 1.5 t80 36.1 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 110.645 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' HIS . 20.8 mmt180 -99.42 -142.54 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.477 -0.764 . . . . 0.0 109.239 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER 58.8 153.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.256 -0.903 . . . . 0.0 109.092 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 165.03 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 0.0 109.27 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -154.29 86.29 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.26 -71.14 0.21 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 t80 -173.01 -96.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -1.088 . . . . 0.0 109.496 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.604 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.1 mt-10 -160.56 -173.05 3.78 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' GLU . 6.8 t -37.79 -28.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.779 -0.576 . . . . 0.0 110.453 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -88.28 38.21 0.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 108.458 178.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 27.8 t60 -154.22 -46.02 0.09 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.51 ' NE2' ' C ' ' A' ' 11' ' ' GLU . 1.9 mt-30 -80.97 -45.66 16.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.531 -0.73 . . . . 0.0 109.667 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -62.55 -26.75 68.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.93 -56.49 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.0 t -49.04 -76.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.522 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.59 -41.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.7 t80 -64.98 -61.48 2.13 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -42.68 -47.47 5.35 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.901 0.858 . . . . 0.0 109.317 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.4 mt-10 -56.64 -45.37 81.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.193 0.521 . . . . 0.0 109.912 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.96 15.99 22.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 20' ' ' PHE . 10.7 t -87.66 157.89 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.643 -0.66 . . . . 0.0 109.238 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -60.95 -56.14 25.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -171.2 51.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.442 ' HB2' HG12 ' A' ' 24' ' ' VAL . 4.1 t-20 -51.56 -52.45 47.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.223 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -47.38 139.83 6.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.558 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.55 -90.9 0.29 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.61 -84.37 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -1.14 . . . . 0.0 109.77 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.69 -30.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 8.9 pt -80.81 -47.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 108.838 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.56 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.74 -21.46 9.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' VAL . 27.2 mt -80.94 -67.15 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -43.76 -25.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.668 -0.645 . . . . 0.0 110.045 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.542 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 89.8 t -86.73 31.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -0.917 . . . . 0.0 109.893 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 81.49 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.33 -58.19 2.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.7 m -128.18 48.13 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -1.156 . . . . 0.0 109.76 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.428 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.07 124.16 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.924 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.06 24.47 11.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.561 ' CE2' ' HG2' ' A' ' 5' ' ' ARG . 8.4 p90 -131.04 -33.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 109.826 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.561 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 25.9 mmm-85 -67.11 -137.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.26 -0.9 . . . . 0.0 109.275 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' CG ' ' C ' ' A' ' 5' ' ' ARG . 24.2 m80 -150.43 -158.54 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 109.884 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -58.54 -21.07 51.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.74 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.8 p -69.15 84.77 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.095 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.66 -66.64 1.53 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 9.5 t80 -110.13 -118.86 0.28 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.113 -1.228 . . . . 0.0 109.845 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 9.1 mt-10 -163.26 -100.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.747 -1.221 . . . . 0.0 109.896 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -53.49 -34.52 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 O-C-N 120.841 -1.162 . . . . 0.0 109.961 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -103.75 60.85 0.75 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.536 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER 175.91 -60.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.485 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 17.1 mm-40 -63.78 -32.0 73.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 109.147 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 5.3 mmmt -71.98 -24.84 61.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -71.4 -54.45 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' PHE . 3.3 t -55.84 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.534 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.8 -42.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.981 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.6 t80 -64.11 -61.23 2.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.92 -46.92 8.32 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.819 0.818 . . . . 0.0 109.43 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.16 -43.3 87.35 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.83 -0.544 . . . . 0.0 109.707 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 16.42 15.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 2.5 t -100.02 161.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -147.15 -46.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.28 43.4 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.405 -1.056 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 28' ' ' LYS . 8.9 m120 -107.17 31.77 5.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.749 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' CG ' HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER 50.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.86 10.07 3.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 31' ' ' ILE . . . -129.48 -60.91 1.04 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.112 -1.228 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 HD12 ' CG ' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -42.26 -34.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.9 pt -71.15 -47.76 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.038 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.581 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -49.7 -24.8 6.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 34.6 mt -62.32 -61.69 2.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -1.002 . . . . 0.0 109.4 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 18.9 ptt? -60.63 -18.36 52.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.746 -0.596 . . . . 0.0 109.741 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 95.7 t -87.08 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.21 -0.932 . . . . 0.0 110.073 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.09 52.75 0.82 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.46 121.32 0.89 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.74 12.16 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.301 179.892 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.61 146.41 45.42 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.13 26.43 7.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.968 . . . . 0.0 109.245 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.7 p90 -156.89 -42.88 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -80.3 80.61 6.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.871 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 7' ' ' ASP . 5.8 t60 -109.77 -160.65 0.72 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.162 -0.961 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' HIS . 17.4 t70 51.94 171.47 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.292 -0.88 . . . . 0.0 109.681 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -102.73 90.0 3.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.919 -1.113 . . . . 0.0 109.542 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.94 48.31 0.72 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 14' ' ' HIS . 2.3 t80 -140.95 -137.1 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -1.129 . . . . 0.0 109.497 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER 73.85 7.61 4.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.995 . . . . 0.0 109.358 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -103.37 -30.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 109.157 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 1.8 m80 -114.49 -39.96 3.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.11 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -61.57 -44.5 96.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -0.995 . . . . 0.0 110.021 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 32.2 mm-40 -55.91 -16.46 4.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 109.992 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.12 -41.21 9.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.092 . . . . 0.0 109.551 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.92 -59.38 3.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.1 t -48.07 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.53 ' C ' ' O ' ' A' ' 18' ' ' VAL . 42.1 t80 -26.47 -43.88 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.807 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -62.25 -60.73 3.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -46.26 -48.7 17.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.739 0.78 . . . . 0.0 109.885 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.34 -36.8 76.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.702 -0.624 . . . . 0.0 110.227 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.26 16.47 24.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 109.587 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 27' ' ' ASN . 4.3 t -91.25 -64.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 93.47 36.87 5.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 75.99 71.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.389 -1.065 . . . . 0.0 109.63 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.54 ' HB2' ' CG1' ' A' ' 24' ' ' VAL . 11.5 t-20 -73.99 -16.11 61.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.397 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 74.02 159.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 0.0 109.215 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 0.24 14.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.36 -76.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -1.155 . . . . 0.0 109.183 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.54 -18.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.287 -0.883 . . . . 0.0 109.076 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 32' ' ' ILE . 1.9 mp -87.62 -38.18 11.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.298 -0.876 . . . . 0.0 109.047 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.28 67.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.52 -54.16 3.9 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.25 -1.147 . . . . 0.0 109.235 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -63.23 -33.19 74.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 67.4 t -88.65 24.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.23 -70.77 1.14 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.95 59.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.74 2.55 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -1.147 . . . . 0.0 109.628 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.558 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.6 166.38 6.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -133.69 106.28 7.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.0 p90 -153.54 -36.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -32.19 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.534 0.683 . . . . 0.0 110.779 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 4' ' ' PHE . 36.2 m80 -105.38 124.61 49.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.617 -0.677 . . . . 0.0 109.179 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.4 OUTLIER -71.38 145.72 49.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER 43.44 75.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 76.29 0.05 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.67 ' CZ ' ' CG ' ' A' ' 14' ' ' HIS . 3.9 t80 179.19 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -1.142 . . . . 0.0 109.366 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.499 ' O ' ' OE1' ' A' ' 15' ' ' GLN . 3.4 mt-10 -44.69 -28.45 0.62 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 109.16 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.92 -17.26 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.397 -0.814 . . . . 0.0 109.117 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' GLN . 3.6 t60 -87.9 -58.44 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.883 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.67 ' CG ' ' CZ ' ' A' ' 10' ' ' TYR . 22.1 t-80 -35.59 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.048 0.451 . . . . 0.0 110.934 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 13' ' ' HIS . 3.6 mp0 -78.32 -53.82 6.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.007 -1.058 . . . . 0.0 109.825 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 3.0 mmtp -52.58 -23.9 7.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.368 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -75.44 -58.9 3.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 21' ' ' ALA . 3.2 t -52.01 -76.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' C ' ' O ' ' A' ' 18' ' ' VAL . 3.0 t80 -27.51 -41.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.656 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.35 -61.82 2.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.57 -48.59 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.762 0.792 . . . . 0.0 109.364 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.79 -42.71 79.94 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.86 -0.525 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.19 15.04 28.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.201 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 20' ' ' PHE . 2.7 t -98.02 -76.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.454 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . 95.4 63.19 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' GLY . 54.5 m 43.07 49.09 5.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -1.089 . . . . 0.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -127.56 20.81 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 0.0 109.404 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.26 -148.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.368 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.91 55.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.81 -90.59 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.127 . . . . 0.0 109.237 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.73 -52.49 9.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -52.51 -39.13 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.63 0.728 . . . . 0.0 109.471 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 32' ' ' ILE . . . -62.24 -37.44 94.56 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -74.86 0.1 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.29 -1.124 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -52.86 59.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 110.482 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 9.5 t -82.65 28.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.074 -1.016 . . . . 0.0 110.953 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 33' ' ' GLY . . . -132.19 15.97 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 -12.54 61.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' O ' HG11 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -91.08 -11.63 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.148 -1.207 . . . . 0.0 108.872 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.431 179.905 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' HD23 ' A' ' 17' ' ' LEU . 11.9 mmtt . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.879 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -78.11 -59.68 2.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -50.25 -75.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.708 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.94 -42.16 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.582 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.4 t80 -62.6 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.1 -47.49 6.08 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.599 0.714 . . . . 0.0 109.673 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.608 ' OE2' HG12 ' A' ' 18' ' ' VAL . 51.0 mt-10 -56.47 -46.91 80.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.653 -0.654 . . . . 0.0 109.969 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.364 0.602 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -78.61 -27.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.379 -0.826 . . . . 0.0 109.407 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.57 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.8 pt -59.44 -46.86 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.82 -25.11 21.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 34' ' ' LEU . 29.1 mt -79.49 -67.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -1.194 . . . . 0.0 109.773 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.5 ptp -50.37 -21.08 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.61 -0.681 . . . . 0.0 109.703 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.791 ' O ' HG12 ' A' ' 36' ' ' VAL . 91.7 t -88.45 28.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.942 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.884 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.85 -52.1 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -52.18 -76.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.33 -42.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.62 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.0 t80 -63.0 -61.63 2.26 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.01 -46.4 8.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.674 0.749 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.9 mt-10 -57.73 -43.11 85.09 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.826 -0.546 . . . . 0.0 109.934 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.907 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.261 0.553 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mp -54.53 -19.87 4.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.219 -0.926 . . . . 0.0 109.887 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 33' ' ' GLY . 14.5 mt -64.71 -45.91 93.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.229 -0.919 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -44.64 -31.4 2.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -65.54 -77.55 0.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.437 -1.037 . . . . 0.0 109.928 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.501 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 1.8 ptt? -40.53 -26.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.814 -0.554 . . . . 0.0 110.285 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.814 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.3 t -84.15 30.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 110.208 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.861 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.515 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 mmmt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.449 0.642 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.863 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.53 -64.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -50.04 -71.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.542 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.11 -41.88 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.443 179.113 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.587 ' N ' ' O ' ' A' ' 18' ' ' VAL . 16.3 t80 -66.01 -63.67 1.03 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -49.22 -49.31 43.62 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.595 0.712 . . . . 0.0 110.192 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.08 -37.21 74.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.755 -0.591 . . . . 0.0 109.991 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.205 0.526 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 31' ' ' ILE . 1.7 mp -96.92 -22.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -93.13 -38.05 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -76.4 1.66 60.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 33' ' ' GLY . 36.0 mt -122.24 -49.87 2.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.604 ' HG3' HG23 ' A' ' 36' ' ' VAL . 18.4 ptm -54.58 -38.16 66.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.76 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.847 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.5 t -86.76 30.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.241 0.543 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.86 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -63.4 -55.66 22.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.4 t -50.76 -76.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.7 t80 -27.24 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.794 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 18' ' ' VAL . 12.6 t80 -63.68 -61.11 2.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -48.51 12.03 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.74 0.781 . . . . 0.0 109.618 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 55.8 mt-10 -58.37 -39.51 79.81 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.646 -0.659 . . . . 0.0 109.898 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.56 -33.75 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.27 -0.893 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 4.9 pt -64.68 -48.51 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 108.836 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -54.56 -29.47 48.22 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.49 -70.13 0.16 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.519 -0.989 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.488 ' HG2' HG23 ' A' ' 36' ' ' VAL . 10.8 ptt? -48.58 -31.46 6.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.743 -0.598 . . . . 0.0 109.807 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 36' ' ' VAL . 42.8 t -86.56 32.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.855 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.84 -55.1 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -46.31 -75.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.9 t80 -27.85 -40.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.767 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -66.24 -59.94 3.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.25 -47.2 12.84 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.785 0.803 . . . . 0.0 109.592 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 18' ' ' VAL . 49.3 mt-10 -58.0 -42.76 85.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.8 -0.562 . . . . 0.0 110.409 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HB ' HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -54.84 -58.74 3.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.2 mp -74.97 -37.26 40.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.0 -8.69 54.68 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -97.34 -53.2 3.54 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.282 -1.128 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.6 ptp -63.08 -26.81 69.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.832 ' O ' HG12 ' A' ' 36' ' ' VAL . 54.3 t -89.2 26.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.859 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.8 -62.68 1.41 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.693 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.57 -75.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.693 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -28.07 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.759 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . 33.4 t80 -66.46 -60.33 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.32 -49.37 12.86 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.737 0.779 . . . . 0.0 109.421 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 56.9 mt-10 -58.79 -40.82 85.16 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.228 0.537 . . . . 0.0 110.324 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.603 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.216 0.532 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.6 ' N ' HD13 ' A' ' 31' ' ' ILE . 1.9 mm -46.56 -41.59 4.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.203 -0.936 . . . . 0.0 109.478 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 mm -66.19 -39.06 83.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.76 -12.54 42.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 34' ' ' LEU . 31.9 mt -91.11 -66.15 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -1.19 . . . . 0.0 109.647 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -48.75 73.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 110.107 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.804 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.1 t -86.47 29.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.163 -0.961 . . . . 0.0 110.062 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 62.2 mmtt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.875 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.72 -50.45 57.41 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.68 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.8 t -51.96 -76.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.91 -42.06 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.84 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -63.56 -60.96 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.69 -45.5 9.79 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.854 0.835 . . . . 0.0 109.716 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 92.4 mt-10 -58.47 -42.45 87.51 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.787 -0.571 . . . . 0.0 109.849 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.114 -0.991 . . . . 0.0 109.859 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.176 0.512 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mt -50.84 -37.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.142 -0.974 . . . . 0.0 110.108 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 32' ' ' ILE . 8.2 mm -73.25 -36.31 49.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.142 -0.974 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.04 6.13 57.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -107.54 -49.6 3.22 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -1.179 . . . . 0.0 109.728 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.484 ' HG3' HG23 ' A' ' 36' ' ' VAL . 24.1 ptt? -47.37 -31.73 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.438 -0.789 . . . . 0.0 110.031 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 36' ' ' VAL . 77.1 t -87.73 34.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.125 0.488 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -72.03 -57.06 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.78 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -26.51 -41.76 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.782 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.0 t80 -65.53 -60.9 2.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.12 -48.35 12.1 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 59.4 mt-10 -59.44 -40.5 86.97 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.903 -0.498 . . . . 0.0 110.323 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.586 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -82.97 -4.45 8.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -76.87 -37.64 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.307 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 32' ' ' ILE . . . -77.57 3.31 60.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 34' ' ' LEU . 41.1 mt -112.0 -45.71 3.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.1 ptm -52.39 -21.73 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.931 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.784 ' O ' HG12 ' A' ' 36' ' ' VAL . 96.7 t -84.9 28.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.253 0.549 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.83 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -62.94 -55.52 25.24 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.76 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.7 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.17 -41.87 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.4 t80 -65.3 -59.79 3.67 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.58 -44.85 9.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.864 0.84 . . . . 0.0 109.419 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.84 -43.28 90.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.218 0.532 . . . . 0.0 109.992 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.714 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.424 0.63 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.18 -39.32 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.47 -0.769 . . . . 0.0 109.21 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -79.68 -40.44 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.357 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.663 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -68.7 -4.97 42.72 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.5 tp -89.02 -48.87 7.12 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.211 . . . . 0.0 109.395 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.1 -11.67 57.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.738 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.826 ' O ' HG12 ' A' ' 36' ' ' VAL . 73.0 t -84.19 26.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 110.369 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.712 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -52.96 -57.89 8.79 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -46.92 -75.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.687 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -29.09 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.69 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -65.67 -59.98 3.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.42 -45.38 12.78 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.833 0.825 . . . . 0.0 109.699 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.67 -41.52 86.33 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.751 -0.593 . . . . 0.0 110.122 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 109.94 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.207 0.527 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.86 -58.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -74.94 -40.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.15 -8.03 41.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 34' ' ' LEU . 33.4 tp -98.34 -51.34 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.213 -1.169 . . . . 0.0 109.402 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 32' ' ' ILE . 12.1 ptp -57.83 -21.22 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.489 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 36' ' ' VAL . 53.0 t -86.15 25.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.89 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.86 -56.35 9.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -49.36 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.51 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.799 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 21.8 t80 -64.55 -61.25 2.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.78 -48.02 8.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.795 0.807 . . . . 0.0 109.454 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 78.8 mt-10 -58.22 -42.31 86.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.213 0.53 . . . . 0.0 110.032 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.894 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' ILE . 1.7 mp -81.64 -25.65 9.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.111 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -70.24 -47.29 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.263 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -66.45 -8.22 44.28 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.8 tp -93.53 -47.38 6.87 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.302 -1.116 . . . . 0.0 109.633 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 2.8 ptt? -47.17 -29.73 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.074 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.795 ' O ' HG12 ' A' ' 36' ' ' VAL . 94.0 t -85.97 31.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.276 -0.89 . . . . 0.0 110.029 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.891 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -76.22 -60.66 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.4 t -49.7 -75.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -27.32 -40.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.759 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.2 t80 -65.06 -60.68 2.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -49.94 11.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.749 0.785 . . . . 0.0 109.492 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 58.9 mt-10 -58.62 -38.56 78.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.745 -0.597 . . . . 0.0 109.994 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.73 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -70.69 -45.06 75.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.228 -0.92 . . . . 0.0 108.586 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -48.08 -61.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 109.516 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -39.61 -36.87 0.76 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 38.9 mt -55.27 -56.64 17.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.36 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 6.3 ptp -66.43 -21.27 66.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.504 -0.748 . . . . 0.0 109.495 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 36' ' ' VAL . 26.2 t -85.84 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.28 0.562 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.874 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -74.58 -58.66 3.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.75 -76.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.703 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t80 -25.88 -42.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.784 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.9 t80 -64.62 -61.76 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.91 -47.51 8.38 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.65 0.738 . . . . 0.0 109.641 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -58.3 -43.39 88.06 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.762 -0.586 . . . . 0.0 110.072 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.833 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -85.93 -28.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 108.737 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.05 -48.51 17.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.38 -8.42 50.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.3 tp -90.37 -50.44 5.96 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.359 -1.083 . . . . 0.0 109.373 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.518 ' HG3' HG23 ' A' ' 36' ' ' VAL . 4.9 ptm -64.6 -38.78 92.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.51 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.768 ' O ' HG12 ' A' ' 36' ' ' VAL . 41.8 t -87.45 17.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.141 -0.974 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.705 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.341 0.591 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.857 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.73 -57.93 3.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.707 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -51.2 -76.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.707 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.5 t80 -25.83 -42.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.778 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 18' ' ' VAL . 6.1 t80 -63.4 -62.55 1.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.63 -47.45 7.58 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.735 0.779 . . . . 0.0 109.823 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 67.4 mt-10 -58.62 -43.03 89.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.706 -0.621 . . . . 0.0 110.357 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 109.999 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.33 -22.24 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 3.9 pt -77.74 -45.08 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.305 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -61.7 -13.59 39.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 34' ' ' LEU . 37.4 mt -74.01 -49.48 24.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -1.185 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.6 ptm -62.75 -35.02 78.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.543 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.824 ' O ' HG12 ' A' ' 36' ' ' VAL . 55.0 t -93.82 24.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.177 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 67.1 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.856 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -73.11 -59.73 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.85 -75.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.57 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.669 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.1 t80 -63.72 -62.17 1.83 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.2 -47.26 9.21 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.796 0.807 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -58.82 -41.59 87.22 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.137 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.076 -1.015 . . . . 0.0 110.06 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.41 -20.34 26.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.053 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.0 mm -76.62 -45.05 33.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.41 -0.806 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.15 -34.76 87.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 34' ' ' LEU . 38.4 mt -71.03 -55.67 7.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -1.11 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -58.95 -26.73 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 109.689 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 36' ' ' VAL . 69.0 t -88.82 25.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.195 0.522 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.886 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.35 -59.37 3.46 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.09 -76.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.702 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.2 t80 -26.95 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.731 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.1 t80 -65.77 -60.77 2.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.49 -48.73 10.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.789 0.804 . . . . 0.0 109.444 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -56.57 -47.69 78.95 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.788 -0.57 . . . . 0.0 110.015 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.215 0.531 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.02 -29.42 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.117 -0.989 . . . . 0.0 109.557 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -74.69 -47.24 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -70.73 -3.83 51.24 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.3 tp -98.71 -53.28 3.35 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.168 -1.196 . . . . 0.0 109.34 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.1 ptm -48.38 -22.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.82 ' O ' HG12 ' A' ' 36' ' ' VAL . 80.7 t -87.19 31.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.337 -0.852 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.652 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.878 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.93 -56.49 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -49.04 -76.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.59 -41.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.7 t80 -64.98 -61.48 2.13 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -42.68 -47.47 5.35 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.901 0.858 . . . . 0.0 109.317 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.4 mt-10 -56.64 -45.37 81.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.193 0.521 . . . . 0.0 109.912 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.328 0.585 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 31' ' ' ILE . 1.1 mp -49.69 -30.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 8.9 pt -80.81 -47.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 108.838 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.56 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.74 -21.46 9.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 34' ' ' LEU . 27.2 mt -80.94 -67.15 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 5.4 ptt? -43.76 -25.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.668 -0.645 . . . . 0.0 110.045 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 36' ' ' VAL . 89.8 t -86.73 31.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -0.917 . . . . 0.0 109.893 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 5.3 mmmt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -71.4 -54.45 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.704 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -55.84 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.704 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.8 -42.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.981 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.6 t80 -64.11 -61.23 2.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.92 -46.92 8.32 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.819 0.818 . . . . 0.0 109.43 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.16 -43.3 87.35 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.83 -0.544 . . . . 0.0 109.707 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.254 0.549 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -42.26 -34.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.9 pt -71.15 -47.76 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.038 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.581 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -49.7 -24.8 6.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 34' ' ' LEU . 34.6 mt -62.32 -61.69 2.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -1.002 . . . . 0.0 109.4 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 18.9 ptt? -60.63 -18.36 52.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.746 -0.596 . . . . 0.0 109.741 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.798 ' O ' HG12 ' A' ' 36' ' ' VAL . 95.7 t -87.08 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.21 -0.932 . . . . 0.0 110.073 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.728 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.92 -59.38 3.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.694 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -48.07 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.694 ' N ' HG12 ' A' ' 18' ' ' VAL . 42.1 t80 -26.47 -43.88 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.807 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -62.25 -60.73 3.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -46.26 -48.7 17.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.739 0.78 . . . . 0.0 109.885 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.34 -36.8 76.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.702 -0.624 . . . . 0.0 110.227 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 109.587 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -73.54 -18.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.287 -0.883 . . . . 0.0 109.076 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 32' ' ' ILE . 1.9 mp -87.62 -38.18 11.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.298 -0.876 . . . . 0.0 109.047 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.28 67.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.52 -54.16 3.9 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.25 -1.147 . . . . 0.0 109.235 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -63.23 -33.19 74.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.804 ' O ' HG12 ' A' ' 36' ' ' VAL . 67.4 t -88.65 24.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.826 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 3.0 mmtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.399 0.619 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.874 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -75.44 -58.9 3.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -52.01 -76.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.699 ' N ' HG12 ' A' ' 18' ' ' VAL . 3.0 t80 -27.51 -41.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.656 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.35 -61.82 2.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.57 -48.59 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.762 0.792 . . . . 0.0 109.364 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.79 -42.71 79.94 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.86 -0.525 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.201 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.73 -52.49 9.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -52.51 -39.13 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.63 0.728 . . . . 0.0 109.471 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.679 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -62.24 -37.44 94.56 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -74.86 0.1 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.29 -1.124 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -52.86 59.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 110.482 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' VAL . 9.5 t -82.65 28.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.074 -1.016 . . . . 0.0 110.953 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 33' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.99 172.81 11.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.253 -0.904 . . . . 0.0 109.587 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' PHE . 1.1 tp10 -150.55 27.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 109.379 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' GLU . 2.8 p90 -40.71 -44.99 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HG3' ' C ' ' A' ' 4' ' ' PHE . 1.9 mtp180 -133.46 -144.11 0.22 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 67.69 22.09 9.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -121.38 106.86 11.83 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.379 -0.826 . . . . 0.0 109.437 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.407 ' C ' ' OE2' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -156.05 -144.66 0.14 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 108.981 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.72 -57.75 0.19 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 8.3 t80 -62.33 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -1.096 . . . . 0.0 108.799 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 15' ' ' GLN . 3.9 mt-10 77.89 7.45 2.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.854 -1.154 . . . . 0.0 110.739 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -96.11 -17.83 6.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.91 -1.119 . . . . 0.0 109.519 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.495 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -141.54 -49.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.502 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -47.32 -30.79 3.38 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.682 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.552 ' CG ' ' HA ' ' A' ' 11' ' ' GLU . 7.5 mm100 -66.2 -52.07 51.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.638 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' HD23 ' A' ' 17' ' ' LEU . 11.9 mmtt -51.67 -23.6 4.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -78.11 -59.68 2.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -50.25 -75.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.708 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.94 -42.16 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.582 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.932 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.4 t80 -62.6 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.1 -47.49 6.08 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.599 0.714 . . . . 0.0 109.673 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.608 ' OE2' HG12 ' A' ' 18' ' ' VAL . 51.0 mt-10 -56.47 -46.91 80.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.653 -0.654 . . . . 0.0 109.969 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.28 14.63 19.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 20' ' ' PHE . 8.0 t -92.51 -78.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.647 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 123.26 -47.35 1.03 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER 164.79 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -1.143 . . . . 0.0 109.642 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -126.1 -138.7 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.905 . . . . 0.0 109.123 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -103.68 160.8 14.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.4 -91.15 0.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.53 -87.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.304 -1.116 . . . . 0.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -78.61 -27.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.379 -0.826 . . . . 0.0 109.407 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.57 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.8 pt -59.44 -46.86 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.82 -25.11 21.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 34' ' ' LEU . 29.1 mt -79.49 -67.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -1.194 . . . . 0.0 109.773 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.5 ptp -50.37 -21.08 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.61 -0.681 . . . . 0.0 109.703 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 36' ' ' VAL . 91.7 t -88.45 28.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.97 45.96 0.52 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.24 -73.19 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.09 -32.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 11.0 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.523 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.408 0.623 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.23 144.14 28.31 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.683 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -112.43 94.21 4.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 109.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -49.2 3.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 109.756 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -96.16 -149.76 0.32 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 109.085 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' ARG . 3.6 t60 41.72 27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.762 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' ARG . 1.1 t0 -154.49 -150.81 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.1 p -118.6 -144.37 0.37 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.204 -0.935 . . . . 0.0 109.191 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 14' ' ' HIS . . . -121.29 -52.69 0.23 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 1.4 t80 -156.21 -119.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.079 . . . . 0.0 109.231 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 9.7 mt-10 -168.2 -59.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 0.0 109.243 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.1 t -82.81 -34.39 11.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.19 -0.944 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -118.67 60.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.586 ' CE1' ' HA3' ' A' ' 9' ' ' GLY . 7.3 t60 -172.17 -41.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.093 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 7.8 mm100 -77.45 -32.91 54.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 108.796 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -85.24 -32.02 22.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.85 -52.1 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -52.18 -76.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.33 -42.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.62 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.735 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.0 t80 -63.0 -61.63 2.26 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.01 -46.4 8.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.674 0.749 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.9 mt-10 -57.73 -43.11 85.09 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.826 -0.546 . . . . 0.0 109.934 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.36 15.92 19.91 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.8 t -90.0 -59.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.79 49.59 3.55 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m 46.39 58.78 4.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.434 ' HB2' HG13 ' A' ' 24' ' ' VAL . 1.4 t-20 -84.96 12.97 6.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -177.01 -176.68 0.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.688 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -161.96 58.31 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.69 -57.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -1.19 . . . . 0.0 109.634 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mp -54.53 -19.87 4.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.219 -0.926 . . . . 0.0 109.887 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.688 HD12 ' HA2' ' A' ' 29' ' ' GLY . 14.5 mt -64.71 -45.91 93.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.229 -0.919 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -44.64 -31.4 2.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -65.54 -77.55 0.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.437 -1.037 . . . . 0.0 109.928 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.501 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 1.8 ptt? -40.53 -26.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.814 -0.554 . . . . 0.0 110.285 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 36' ' ' VAL . 78.3 t -84.15 30.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 110.208 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.56 -65.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 110.46 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.38 -17.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.515 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.306 0.574 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' HB3' ' HE1' ' A' ' 4' ' ' PHE . . . -73.38 170.87 14.17 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.566 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.13 99.34 4.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -125.4 -59.38 1.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.825 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 76.46 7.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.753 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.8 111.49 6.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -52.13 168.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -109.25 28.41 8.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.33 70.36 0.23 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 14' ' ' HIS . 5.5 t80 -74.27 -129.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 108.887 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 51.79 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.765 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' TYR . 3.4 t -47.35 -23.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 110.209 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -97.61 48.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 109.691 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.565 ' O ' HG23 ' A' ' 18' ' ' VAL . 43.3 t60 179.64 -61.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.463 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 38.3 mm-40 -56.57 -54.59 44.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.304 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 mmmt -42.35 -27.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.53 -64.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -50.04 -71.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.542 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.11 -41.88 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.443 179.113 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 1.025 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.3 t80 -66.01 -63.67 1.03 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -49.22 -49.31 43.62 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.595 0.712 . . . . 0.0 110.192 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.08 -37.21 74.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.755 -0.591 . . . . 0.0 109.991 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 16.56 23.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.025 HG23 ' O ' ' A' ' 20' ' ' PHE . 8.2 t -92.28 -45.31 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.61 -41.95 2.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.629 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -172.08 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -1.066 . . . . 0.0 109.322 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.86 ' ND2' HG21 ' A' ' 24' ' ' VAL . 1.3 m-20 -65.32 86.24 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.473 -0.767 . . . . 0.0 109.395 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -52.71 -70.14 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.457 -0.777 . . . . 0.0 109.473 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.69 75.09 0.68 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.07 -61.23 1.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -1.101 . . . . 0.0 109.931 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 31' ' ' ILE . 1.7 mp -96.92 -22.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -93.13 -38.05 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -76.4 1.66 60.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 33' ' ' GLY . 36.0 mt -122.24 -49.87 2.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.604 ' HG3' HG23 ' A' ' 36' ' ' VAL . 18.4 ptm -54.58 -38.16 66.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.76 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 36' ' ' VAL . 78.5 t -86.76 30.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 34.12 4.13 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.45 -129.9 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.04 29.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -1.115 . . . . 0.0 109.443 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.507 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.7 32.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.193 -0.942 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -107.26 93.64 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 5' ' ' ARG . 0.9 OUTLIER -124.26 -174.19 2.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.858 . . . . 0.0 109.63 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' PHE . 2.0 mpt_? 61.92 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.91 166.17 16.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.628 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -145.12 137.47 25.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.0 109.326 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -75.74 81.24 2.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.594 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.18 84.77 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -105.35 -74.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.2 -1.177 . . . . 0.0 108.934 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 2.2 mt-10 64.49 -97.83 0.06 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.426 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.6 t -45.16 -24.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.682 -1.261 . . . . 0.0 109.742 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -100.4 47.58 0.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.504 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER 177.39 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.934 -1.104 . . . . 0.0 110.216 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 32.4 mm-40 -71.96 -57.7 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -58.35 -37.95 76.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.757 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.86 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -63.4 -55.66 22.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.4 t -50.76 -76.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.7 t80 -27.24 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.794 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.551 ' CD2' HG21 ' A' ' 24' ' ' VAL . 12.6 t80 -63.68 -61.11 2.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -48.51 12.03 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.74 0.781 . . . . 0.0 109.618 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 55.8 mt-10 -58.37 -39.51 79.81 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.646 -0.659 . . . . 0.0 109.898 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.68 15.84 26.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.752 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.551 HG21 ' CD2' ' A' ' 20' ' ' PHE . 2.5 t -101.91 -61.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 96.93 43.88 2.97 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 48.64 49.8 18.1 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.441 -1.035 . . . . 0.0 109.419 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 61.6 t30 -57.18 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 66.74 79.97 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.76 29.33 0.75 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.02 -63.05 1.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -1.073 . . . . 0.0 109.533 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.56 -33.75 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.27 -0.893 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 4.9 pt -64.68 -48.51 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 108.836 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -54.56 -29.47 48.22 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.49 -70.13 0.16 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.519 -0.989 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.488 ' HG2' HG23 ' A' ' 36' ' ' VAL . 10.8 ptt? -48.58 -31.46 6.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.743 -0.598 . . . . 0.0 109.807 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 36' ' ' VAL . 42.8 t -86.56 32.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.78 18.18 22.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.82 70.48 0.52 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.49 26.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -1.145 . . . . 0.0 109.527 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.352 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.487 ' HB1' ' CZ ' ' A' ' 4' ' ' PHE . . . -68.8 -178.65 1.24 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -148.53 25.28 0.97 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CZ ' ' HB1' ' A' ' 2' ' ' ALA . 2.2 p90 -124.48 176.96 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' A' ' 6' ' ' HIS . 3.4 mpt_? 66.28 76.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.481 ' CB ' ' O ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER 73.54 -167.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -148.13 -44.15 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.13 121.64 0.1 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.43 -68.47 1.65 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 17.1 t80 -120.85 -118.26 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -1.117 . . . . 0.0 109.157 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 7.4 mt-10 -164.87 -95.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.737 -1.227 . . . . 0.0 109.898 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.8 t -50.83 -39.82 19.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.938 -1.101 . . . . 0.0 110.455 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 94.8 m-70 -109.82 68.89 0.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 110.237 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.528 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 5.3 t-80 177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.04 . . . . 0.0 110.277 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 38.9 mm-40 -57.18 -16.64 8.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 0.0 110.142 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -88.2 -32.49 18.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.053 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.84 -55.1 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -46.31 -75.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.9 t80 -27.85 -40.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.767 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.732 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -66.24 -59.94 3.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.25 -47.2 12.84 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.785 0.803 . . . . 0.0 109.592 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 18' ' ' VAL . 49.3 mt-10 -58.0 -42.76 85.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.8 -0.562 . . . . 0.0 110.409 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.97 16.27 14.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.5 t -95.5 -57.6 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.81 39.16 5.3 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.78 63.23 2.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.442 -1.034 . . . . 0.0 109.585 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.63 ' HB2' HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -74.29 -76.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.534 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -119.71 119.94 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.568 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.21 27.66 0.62 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.48 -68.92 0.88 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HB ' HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -54.84 -58.74 3.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 32' ' ' ILE . 2.2 mp -74.97 -37.26 40.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.0 -8.69 54.68 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -97.34 -53.2 3.54 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.282 -1.128 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.6 ptp -63.08 -26.81 69.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 36' ' ' VAL . 54.3 t -89.2 26.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 158.66 84.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.72 50.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.57 11.11 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.394 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.481 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.32 128.86 33.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.69 25.83 10.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.544 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -137.19 -50.04 0.63 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 110.035 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.72 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 110.082 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -179.52 101.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.763 . . . . 0.0 109.506 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.77 128.98 9.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.504 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.81 108.63 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 0.0 109.573 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.82 71.3 0.08 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 14' ' ' HIS . 20.2 t80 -118.85 -102.52 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -1.168 . . . . 0.0 109.748 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 16.0 mt-10 -162.6 -168.33 1.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.23 . . . . 0.0 111.139 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.2 t -34.19 -34.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.218 0.532 . . . . 0.0 110.538 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -87.45 40.76 0.94 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.015 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . 56.3 t-80 -159.09 -45.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.931 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 3.8 mm100 -69.43 -48.63 60.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -58.85 -24.65 62.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 109.645 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.8 -62.68 1.41 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.693 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.57 -75.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.693 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -28.07 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.759 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.702 ' O ' HG23 ' A' ' 24' ' ' VAL . 33.4 t80 -66.46 -60.33 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.32 -49.37 12.86 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.737 0.779 . . . . 0.0 109.421 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 56.9 mt-10 -58.79 -40.82 85.16 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.228 0.537 . . . . 0.0 110.324 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.06 17.02 16.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.603 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.7 t -103.03 157.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -138.99 -47.03 0.06 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.84 35.07 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.321 -1.106 . . . . 0.0 109.197 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -45.32 -64.62 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -127.57 -33.06 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.581 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.52 88.57 1.76 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.13 -64.11 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.708 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.6 ' N ' HD13 ' A' ' 31' ' ' ILE . 1.9 mm -46.56 -41.59 4.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.203 -0.936 . . . . 0.0 109.478 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 mm -66.19 -39.06 83.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.76 -12.54 42.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 34' ' ' LEU . 31.9 mt -91.11 -66.15 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -1.19 . . . . 0.0 109.647 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -48.75 73.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 110.107 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 36' ' ' VAL . 78.1 t -86.47 29.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.163 -0.961 . . . . 0.0 110.062 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -135.51 57.64 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.82 33.74 2.43 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.42 6.97 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 ' OXT' ' A' ' 40' ' ' VAL . 3.6 t . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.04 167.26 0.17 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.176 -0.952 . . . . 0.0 109.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -119.81 98.05 5.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 5' ' ' ARG . 12.1 p90 -161.46 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.659 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -108.87 90.24 3.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.51 -153.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 108.984 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -47.09 165.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.047 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -102.99 -142.44 0.36 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.347 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.09 -74.05 0.26 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 4.9 t80 -111.85 -93.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.04 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.637 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 9.9 mt-10 -156.26 -168.91 2.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.906 -1.121 . . . . 0.0 110.389 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.4 t -40.63 -29.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 O-C-N 121.597 -0.689 . . . . 0.0 109.832 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' O ' HD11 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -88.77 40.07 0.95 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 55.8 t-80 -158.05 -44.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -60.1 2.37 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.411 -0.805 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 62.2 mmtt -47.43 -26.12 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.085 -1.009 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.72 -50.45 57.41 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.68 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.8 t -51.96 -76.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.91 -42.06 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.84 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.768 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -63.56 -60.96 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.69 -45.5 9.79 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.854 0.835 . . . . 0.0 109.716 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 92.4 mt-10 -58.47 -42.45 87.51 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.787 -0.571 . . . . 0.0 109.849 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.16 16.03 17.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.114 -0.991 . . . . 0.0 109.859 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 20' ' ' PHE . 5.6 t -91.14 164.88 2.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -82.4 -58.09 2.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.61 54.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -1.225 . . . . 0.0 109.586 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.493 ' O ' HG21 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -97.09 -59.13 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.499 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -139.2 97.96 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.94 -86.49 1.21 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.99 -70.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.054 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mt -50.84 -37.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.142 -0.974 . . . . 0.0 110.108 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 27' ' ' ASN . 8.2 mm -73.25 -36.31 49.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.142 -0.974 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.04 6.13 57.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -107.54 -49.6 3.22 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -1.179 . . . . 0.0 109.728 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.484 ' HG3' HG23 ' A' ' 36' ' ' VAL . 24.1 ptt? -47.37 -31.73 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.438 -0.789 . . . . 0.0 110.031 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 36' ' ' VAL . 77.1 t -87.73 34.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.47 -61.16 2.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 39' ' ' VAL . . . 106.3 26.85 5.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 40' ' ' VAL . 15.1 m 40.67 37.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.971 . . . . 0.0 109.768 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 39' ' ' VAL . 8.6 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.81 -1.091 . . . . 0.0 109.443 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.36 176.04 5.65 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.216 -0.927 . . . . 0.0 109.709 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.28 95.1 4.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.461 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' HG3' ' A' ' 5' ' ' ARG . 31.4 p90 -157.59 -36.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.557 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 22.9 mtt180 -60.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.425 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -115.39 146.11 41.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -112.57 -61.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 4.7 t 72.64 58.28 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.47 74.49 0.02 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 12.0 t80 -90.45 -99.64 0.1 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 36.8 mt-10 -157.81 -154.11 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.939 -1.101 . . . . 0.0 110.228 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 t -38.4 -35.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 110.381 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.2 40.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 109.183 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 9.4 t60 -164.81 -42.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 25.4 mm-40 -68.92 -51.21 42.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.517 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -58.24 -27.94 64.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.722 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -72.03 -57.06 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.78 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -26.51 -41.76 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.782 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.0 t80 -65.53 -60.9 2.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.12 -48.35 12.1 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 59.4 mt-10 -59.44 -40.5 86.97 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.903 -0.498 . . . . 0.0 110.323 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.42 15.49 15.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.586 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.1 t -100.51 -67.29 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 91.66 43.54 4.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.7 69.3 0.7 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -1.075 . . . . 0.0 109.237 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 1.5 t30 -81.76 78.63 8.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 1.7 ptpt 41.15 30.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 0.0 110.194 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 81.82 1.25 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.34 -67.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -82.97 -4.45 8.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -76.87 -37.64 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.307 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 32' ' ' ILE . . . -77.57 3.31 60.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 34' ' ' LEU . 41.1 mt -112.0 -45.71 3.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.1 ptm -52.39 -21.73 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.931 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 36' ' ' VAL . 96.7 t -84.9 28.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.38 73.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.31 113.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -74.87 -38.64 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.226 -1.161 . . . . 0.0 109.092 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 39' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.313 0.577 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.02 171.25 12.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -123.29 98.69 5.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -128.31 -39.59 1.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.535 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -50.19 88.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.632 -0.667 . . . . 0.0 109.625 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.2 t-160 -125.17 23.64 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.89 -163.37 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 76.7 p -156.0 100.43 2.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.94 60.17 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -168.44 -131.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.105 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' TYR . 27.7 mt-10 79.23 6.86 2.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.98 -11.99 8.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.12 -45.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.865 . . . . 0.0 109.887 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 1.4 t60 -57.76 -23.37 51.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.244 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 15.9 mm100 -60.36 -33.74 72.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.073 -1.017 . . . . 0.0 110.307 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -72.21 -39.36 68.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.855 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -62.94 -55.52 25.24 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.76 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.7 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.17 -41.87 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.677 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.4 t80 -65.3 -59.79 3.67 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.58 -44.85 9.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.864 0.84 . . . . 0.0 109.419 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.84 -43.28 90.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.218 0.532 . . . . 0.0 109.992 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.98 16.22 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.714 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.5 t -96.8 160.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -89.53 -41.43 5.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.15 71.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -1.152 . . . . 0.0 109.445 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.53 6.09 25.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt 52.14 -173.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -129.08 50.75 0.88 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.88 -50.55 2.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.18 -39.32 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.47 -0.769 . . . . 0.0 109.21 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -79.68 -40.44 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.357 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.663 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -68.7 -4.97 42.72 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 38' ' ' GLY . 33.5 tp -89.02 -48.87 7.12 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.211 . . . . 0.0 109.395 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.1 -11.67 57.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.738 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 36' ' ' VAL . 73.0 t -84.19 26.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 110.369 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.55 67.05 0.53 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 34' ' ' LEU . . . -152.64 71.92 0.28 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 40' ' ' VAL . 8.5 m -137.62 -43.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -1.091 . . . . 0.0 109.479 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' N ' HG23 ' A' ' 39' ' ' VAL . 21.1 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.277 0.561 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.44 171.46 0.19 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.246 -0.909 . . . . 0.0 109.558 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.92 105.48 8.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.6 p90 -147.32 176.74 9.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.3 101.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 6' ' ' HIS . 1.3 p-80 -117.83 162.5 18.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.602 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -146.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.18 -142.92 0.35 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.207 -0.933 . . . . 0.0 109.165 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 14' ' ' HIS . . . -113.68 -70.21 0.53 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 6.7 t80 -179.75 -108.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 2.3 mt-10 -169.43 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.8 -1.187 . . . . 0.0 110.212 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.6 -39.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.904 -1.123 . . . . 0.0 110.11 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.03 58.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 1.8 t60 -175.0 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 10.5 mm100 -62.77 -35.87 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.36 -0.837 . . . . 0.0 109.052 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.74 -42.44 77.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.394 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -52.96 -57.89 8.79 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -46.92 -75.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.687 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -29.09 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.69 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -65.67 -59.98 3.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.42 -45.38 12.78 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.833 0.825 . . . . 0.0 109.699 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.67 -41.52 86.33 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.751 -0.593 . . . . 0.0 110.122 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.21 15.63 18.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 109.94 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 20' ' ' PHE . 5.1 t -89.44 -47.66 14.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 90.84 30.26 11.75 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 69.04 68.56 0.27 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.575 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 24' ' ' VAL . 51.9 m-80 -143.15 59.3 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.394 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -113.72 128.84 56.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . . . 156.78 85.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.35 -57.55 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.645 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.86 -58.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -74.94 -40.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA3' ' CA ' ' A' ' 29' ' ' GLY . . . -66.15 -8.03 41.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 34' ' ' LEU . 33.4 tp -98.34 -51.34 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.213 -1.169 . . . . 0.0 109.402 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 32' ' ' ILE . 12.1 ptp -57.83 -21.22 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.489 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 36' ' ' VAL . 53.0 t -86.15 25.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 21.88 28.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.42 7.83 64.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -115.7 0.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -1.182 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.915 -1.04 . . . . 0.0 109.374 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.34 158.47 24.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -126.95 94.77 4.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CE2' ' HD3' ' A' ' 5' ' ' ARG . 9.2 p90 -171.38 -159.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.751 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.533 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 65.23 104.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.677 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -157.54 171.33 20.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.427 -0.795 . . . . 0.0 109.133 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.41 -73.01 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' ' NE2' ' A' ' 14' ' ' HIS . 45.6 t 47.47 64.62 1.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.447 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.4 41.09 0.1 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' HB3' ' CB ' ' A' ' 14' ' ' HIS . 8.6 t80 -106.54 -102.14 0.34 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -1.221 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.54 ' HG3' ' CD1' ' A' ' 10' ' ' TYR . 57.9 mt-10 -157.44 -166.94 2.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.72 -1.238 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.6 t -39.33 -34.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.764 -0.585 . . . . 0.0 110.043 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -85.64 39.63 0.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 108.752 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.566 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . 9.4 t60 -158.42 -42.76 0.06 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.466 -0.771 . . . . 0.0 109.589 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 5.9 mm100 -65.39 -9.71 27.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -98.43 -35.7 10.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.349 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.86 -56.35 9.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -49.36 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.51 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.799 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.896 ' O ' HG23 ' A' ' 24' ' ' VAL . 21.8 t80 -64.55 -61.25 2.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.78 -48.02 8.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.795 0.807 . . . . 0.0 109.454 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 78.8 mt-10 -58.22 -42.31 86.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.213 0.53 . . . . 0.0 110.032 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.2 17.35 17.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.894 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.4 t -90.51 159.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -94.16 -53.29 1.76 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -168.96 63.45 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -1.125 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.32 65.31 9.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.613 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -51.08 163.37 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.24 76.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.03 -54.42 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -1.095 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 31' ' ' ILE . 1.7 mp -81.64 -25.65 9.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.111 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -70.24 -47.29 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.263 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -66.45 -8.22 44.28 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.8 tp -93.53 -47.38 6.87 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.302 -1.116 . . . . 0.0 109.633 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 2.8 ptt? -47.17 -29.73 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.074 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 36' ' ' VAL . 94.0 t -85.97 31.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.276 -0.89 . . . . 0.0 110.029 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.05 10.59 5.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.82 85.27 0.36 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' A' ' 40' ' ' VAL . 29.3 m -130.0 32.34 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.219 -1.165 . . . . 0.0 109.392 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 40' ' ' VAL . 15.0 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.367 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' HB1' ' CE2' ' A' ' 4' ' ' PHE . . . -47.63 130.88 14.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HB3' HG21 ' A' ' 31' ' ' ILE . 2.6 tt0 -131.99 24.71 4.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 45.9 p90 -70.99 156.31 39.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.067 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' PHE . 1.7 mpt_? 68.27 116.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 109.114 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -43.47 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.99 -149.96 0.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -149.48 116.28 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.181 -0.949 . . . . 0.0 109.3 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 8' ' ' SER . . . -43.82 -50.79 7.18 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.1 t80 -150.38 -128.48 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.161 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.544 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 15.2 mt-10 -167.65 -37.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.826 -1.171 . . . . 0.0 109.787 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.53 -37.79 7.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.155 -0.965 . . . . 0.0 109.838 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' HIS . 31.5 m170 -101.78 -49.39 3.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.074 -1.016 . . . . 0.0 110.059 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 11.8 t-160 -42.92 -29.95 0.37 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.967 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 6.6 mm100 -66.45 -54.85 19.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.633 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -47.15 -26.58 1.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.372 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.891 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -76.22 -60.66 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.4 t -49.7 -75.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -27.32 -40.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.759 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.931 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.2 t80 -65.06 -60.68 2.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -49.94 11.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.749 0.785 . . . . 0.0 109.492 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 58.9 mt-10 -58.62 -38.56 78.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.745 -0.597 . . . . 0.0 109.994 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.12 16.77 25.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.73 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 20' ' ' PHE . 5.0 t -90.08 -71.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 143.44 -48.88 0.73 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -173.84 46.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -1.195 . . . . 0.0 109.772 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 33.1 t30 -46.7 -75.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 109.128 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 76.58 133.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 109.77 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.4 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.04 -88.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -1.091 . . . . 0.0 109.32 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -70.69 -45.06 75.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.228 -0.92 . . . . 0.0 108.586 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -48.08 -61.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 109.516 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -39.61 -36.87 0.76 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 38.9 mt -55.27 -56.64 17.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.36 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 6.3 ptp -66.43 -21.27 66.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.504 -0.748 . . . . 0.0 109.495 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 36' ' ' VAL . 26.2 t -85.84 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.24 -79.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.79 49.53 28.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -102.27 18.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.497 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 40' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.7 179.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.064 -1.023 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -178.82 30.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.704 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 5' ' ' ARG . 37.2 p90 -96.78 -43.13 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.545 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.597 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -116.2 -148.97 0.44 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.152 -0.967 . . . . 0.0 109.049 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 0.0 109.557 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -120.46 -86.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.371 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -178.01 109.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.93 -89.1 1.32 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 4.4 t80 -131.65 -135.24 0.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.182 . . . . 0.0 109.3 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 21.8 mt-10 -164.02 -38.38 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.892 -1.13 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -93.23 -14.06 8.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.192 -0.943 . . . . 0.0 109.846 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 14' ' ' HIS . 1.2 t60 -129.45 -57.71 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 109.768 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 7.9 t60 -42.89 -29.7 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 9.8 mm100 -73.34 -50.85 19.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.787 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -55.91 -23.78 33.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.874 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -74.58 -58.66 3.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.75 -76.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.703 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t80 -25.88 -42.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.784 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.9 t80 -64.62 -61.76 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.91 -47.51 8.38 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.65 0.738 . . . . 0.0 109.641 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -58.3 -43.39 88.06 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.762 -0.586 . . . . 0.0 110.072 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.47 16.4 10.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.833 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.78 HG12 ' N ' ' A' ' 25' ' ' GLY . 3.7 t -106.51 -82.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.78 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 119.83 -46.56 1.11 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER 167.13 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -1.138 . . . . 0.0 109.303 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -75.82 -65.35 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 151.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.408 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.28 47.88 27.37 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.97 -61.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -1.161 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -85.93 -28.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 108.737 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.05 -48.51 17.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.38 -8.42 50.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.3 tp -90.37 -50.44 5.96 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.359 -1.083 . . . . 0.0 109.373 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.518 ' HG3' HG23 ' A' ' 36' ' ' VAL . 4.9 ptm -64.6 -38.78 92.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.51 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 36' ' ' VAL . 41.8 t -87.45 17.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.141 -0.974 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.72 31.24 4.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.68 97.36 0.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG23 ' N ' ' A' ' 40' ' ' VAL . 4.2 m -94.8 -37.72 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -1.135 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG13 ' OXT' ' A' ' 40' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.27 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 5' ' ' ARG . . . -81.85 117.65 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.16 7.58 17.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.676 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 5' ' ' ARG . 22.7 p90 -91.55 -32.49 15.52 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.732 -0.605 . . . . 0.0 109.719 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.613 ' HD2' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -83.16 78.08 9.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -115.36 139.46 49.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.5 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.52 -159.11 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 109.553 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 t -124.32 59.1 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.07 -68.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 14' ' ' HIS . 1.6 t80 -157.38 -143.83 0.12 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -1.152 . . . . 0.0 109.256 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 29.1 mt-10 69.77 0.62 3.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.7 -17.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.884 -1.135 . . . . 0.0 109.299 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -130.64 54.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -170.26 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -72.38 -31.33 65.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -74.29 -25.7 59.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.487 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.857 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.73 -57.93 3.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.707 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -51.2 -76.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.707 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.5 t80 -25.83 -42.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.778 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 18' ' ' VAL . 6.1 t80 -63.4 -62.55 1.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.63 -47.45 7.58 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.735 0.779 . . . . 0.0 109.823 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 67.4 mt-10 -58.62 -43.03 89.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.706 -0.621 . . . . 0.0 110.357 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.06 15.11 6.4 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 109.999 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 2.9 t -116.79 159.09 17.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -102.49 -38.35 3.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.74 65.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -1.145 . . . . 0.0 109.234 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -51.79 -92.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.592 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -178.74 -77.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.41 64.5 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.8 -54.89 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.243 . . . . 0.0 109.391 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.33 -22.24 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 3.9 pt -77.74 -45.08 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.305 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -61.7 -13.59 39.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 34' ' ' LEU . 37.4 mt -74.01 -49.48 24.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -1.185 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.6 ptm -62.75 -35.02 78.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.543 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 36' ' ' VAL . 55.0 t -93.82 24.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.177 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.89 -45.97 11.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.53 -129.17 2.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' HB ' ' A' ' 40' ' ' VAL . 14.4 m -118.44 38.11 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -1.143 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 39' ' ' VAL . 5.1 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.41 119.63 14.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' A' ' 3' ' ' GLU . 9.0 tt0 -94.04 27.26 2.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -140.88 -54.78 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.467 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -126.47 -154.74 0.65 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 7' ' ' ASP . 2.3 m-70 -120.25 134.91 55.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.027 -1.046 . . . . 0.0 109.836 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' HIS . 32.6 t0 37.91 -130.1 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.638 -0.664 . . . . 0.0 110.23 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.99 125.51 2.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 109.084 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.58 -55.09 28.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CB ' ' HB2' ' A' ' 14' ' ' HIS . 0.9 OUTLIER -117.68 -132.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.238 . . . . 0.0 110.213 -179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 28.8 mt-10 -163.89 -32.93 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' N ' HE22 ' A' ' 15' ' ' GLN . 3.7 t -110.1 -26.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 121.057 -1.027 . . . . 0.0 110.603 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -114.87 -28.76 6.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.622 -1.298 . . . . 0.0 111.22 -178.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 10' ' ' TYR . 52.5 t-80 -60.54 -11.98 8.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 110.357 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.494 ' NE2' ' C ' ' A' ' 11' ' ' GLU . 2.7 mp0 -85.63 -51.38 6.51 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.492 -0.755 . . . . 0.0 109.708 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 67.1 mmtt -55.3 -26.13 38.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.248 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.856 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -73.11 -59.73 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.85 -75.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.57 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.669 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.822 ' O ' HG23 ' A' ' 24' ' ' VAL . 49.1 t80 -63.72 -62.17 1.83 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.2 -47.26 9.21 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.796 0.807 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -58.82 -41.59 87.22 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.137 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 13.93 23.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.076 -1.015 . . . . 0.0 110.06 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.8 t -86.79 159.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -99.75 -52.33 1.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -171.56 58.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -1.156 . . . . 0.0 109.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -99.24 61.23 1.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -113.43 144.19 43.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.176 -0.953 . . . . 0.0 109.634 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.14 45.95 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.7 -82.61 0.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -1.147 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.41 -20.34 26.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.053 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.0 mm -76.62 -45.05 33.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.41 -0.806 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.15 -34.76 87.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 34' ' ' LEU . 38.4 mt -71.03 -55.67 7.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -1.11 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -58.95 -26.73 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 109.689 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 36' ' ' VAL . 69.0 t -88.82 25.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.88 74.67 1.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.14 -25.1 14.97 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 40' ' ' VAL . 23.7 m -138.47 -46.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -1.202 . . . . 0.0 109.687 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' HG23 ' A' ' 39' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 109.587 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.16 136.01 56.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -100.53 30.75 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -167.69 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 6' ' ' HIS . 1.5 tpt180 -72.49 -145.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.09 -1.006 . . . . 0.0 109.363 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 5' ' ' ARG . 4.7 m170 47.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.596 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -79.4 -78.92 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.661 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 56.39 50.98 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.358 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.35 70.96 1.03 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 13.5 t80 -91.78 -97.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -1.187 . . . . 0.0 109.733 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 67.7 mt-10 -157.5 -145.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.856 -1.152 . . . . 0.0 110.073 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 11' ' ' GLU . 4.4 t -37.77 -41.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.05 45.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 7' ' ' ASP . 11.6 t60 -166.12 -40.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.945 . . . . 0.0 110.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -67.7 -62.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -44.9 -35.93 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.886 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.35 -59.37 3.46 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.09 -76.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.702 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.2 t80 -26.95 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.731 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.1 t80 -65.77 -60.77 2.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.49 -48.73 10.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.789 0.804 . . . . 0.0 109.444 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -56.57 -47.69 78.95 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.788 -0.57 . . . . 0.0 110.015 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 14.51 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.818 HG12 ' N ' ' A' ' 25' ' ' GLY . 3.4 t -108.32 -84.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.818 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 128.98 -38.37 2.04 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.613 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -174.2 59.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -1.22 . . . . 0.0 109.963 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB2' HG11 ' A' ' 24' ' ' VAL . 2.4 t30 -67.45 -57.52 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 109.23 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.15 173.13 15.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.399 -0.813 . . . . 0.0 109.189 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.41 83.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.8 -58.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -1.077 . . . . 0.0 109.916 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.02 -29.42 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.117 -0.989 . . . . 0.0 109.557 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -74.69 -47.24 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -70.73 -3.83 51.24 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.3 tp -98.71 -53.28 3.35 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.168 -1.196 . . . . 0.0 109.34 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.1 ptm -48.38 -22.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 36' ' ' VAL . 80.7 t -87.19 31.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.337 -0.852 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.69 20.02 21.41 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.05 -12.21 3.87 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 120.999 -1.295 . . . . 0.0 109.933 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.18 43.6 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.101 -1.235 . . . . 0.0 109.505 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HB ' HG13 ' A' ' 36' ' ' VAL . 13.7 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.38 132.69 35.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 4' ' ' PHE . 2.8 mt-10 -67.77 -10.73 55.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 0.0 108.557 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLU . 1.5 t80 36.1 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 110.645 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' HIS . 20.8 mmt180 -99.42 -142.54 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.477 -0.764 . . . . 0.0 109.239 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER 58.8 153.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.256 -0.903 . . . . 0.0 109.092 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 165.03 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 0.0 109.27 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -154.29 86.29 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.26 -71.14 0.21 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 t80 -173.01 -96.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -1.088 . . . . 0.0 109.496 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.604 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.1 mt-10 -160.56 -173.05 3.78 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' GLU . 6.8 t -37.79 -28.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.779 -0.576 . . . . 0.0 110.453 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -88.28 38.21 0.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 108.458 178.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 37.9 t-80 -154.22 -46.02 0.09 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -45.66 16.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.531 -0.73 . . . . 0.0 109.667 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -62.55 -26.75 68.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.93 -56.49 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -49.04 -76.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.59 -41.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.977 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.7 t80 -64.98 -61.48 2.13 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -42.68 -47.47 5.35 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.901 0.858 . . . . 0.0 109.317 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.4 mt-10 -56.64 -45.37 81.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.193 0.521 . . . . 0.0 109.912 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.96 15.99 22.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 20' ' ' PHE . 10.7 t -87.66 157.89 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.643 -0.66 . . . . 0.0 109.238 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -60.95 -56.14 25.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -171.2 51.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' HB2' HG11 ' A' ' 24' ' ' VAL . 4.1 t-20 -51.56 -52.45 47.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.223 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -47.38 139.83 6.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.558 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.55 -90.9 0.29 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.61 -84.37 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -1.14 . . . . 0.0 109.77 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 31' ' ' ILE . 1.1 mp -49.69 -30.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 8.9 pt -80.81 -47.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 108.838 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.56 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.74 -21.46 9.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 34' ' ' LEU . 27.2 mt -80.94 -67.15 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 5.4 ptt? -43.76 -25.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.668 -0.645 . . . . 0.0 110.045 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 36' ' ' VAL . 89.8 t -86.73 31.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -0.917 . . . . 0.0 109.893 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 81.49 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.33 -58.19 2.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.7 m -128.18 48.13 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -1.156 . . . . 0.0 109.76 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.428 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.07 124.16 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.924 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.06 24.47 11.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.567 ' CE2' ' HG2' ' A' ' 5' ' ' ARG . 8.4 p90 -131.04 -33.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 109.826 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.567 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 25.9 mmm-85 -67.11 -137.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.26 -0.9 . . . . 0.0 109.275 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' CG ' ' C ' ' A' ' 5' ' ' ARG . 24.2 m80 -150.43 -158.54 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 109.884 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -58.54 -21.07 51.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.74 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.8 p -69.15 84.77 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.095 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.66 -66.64 1.53 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 9.5 t80 -110.13 -118.86 0.28 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.113 -1.228 . . . . 0.0 109.845 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 9.1 mt-10 -163.26 -100.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.747 -1.221 . . . . 0.0 109.896 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 12' ' ' VAL . 5.1 t -53.49 -34.52 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 O-C-N 120.841 -1.162 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -103.75 60.85 0.75 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.52 ' CA ' ' HG ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 175.91 -60.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.485 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm100 -63.78 -32.0 73.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 109.147 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 5.3 mmmt -71.98 -24.84 61.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -71.4 -54.45 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.704 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -55.84 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.704 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.8 -42.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.981 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.6 t80 -64.11 -61.23 2.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.92 -46.92 8.32 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.819 0.818 . . . . 0.0 109.43 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.16 -43.3 87.35 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.83 -0.544 . . . . 0.0 109.707 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 16.42 15.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 2.5 t -100.02 161.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -147.15 -46.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.28 43.4 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.405 -1.056 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 28' ' ' LYS . 8.9 m120 -107.17 31.77 5.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.749 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' CG ' HD13 ' A' ' 31' ' ' ILE . 0.6 OUTLIER 50.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.86 10.07 3.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 31' ' ' ILE . . . -129.48 -60.91 1.04 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.112 -1.228 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD13 ' CG ' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -42.26 -34.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.9 pt -71.15 -47.76 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.038 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.581 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -49.7 -24.8 6.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 34' ' ' LEU . 34.6 mt -62.32 -61.69 2.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -1.002 . . . . 0.0 109.4 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 18.9 ptt? -60.63 -18.36 52.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.746 -0.596 . . . . 0.0 109.741 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 36' ' ' VAL . 95.7 t -87.08 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.21 -0.932 . . . . 0.0 110.073 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.09 52.75 0.82 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.46 121.32 0.89 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.74 12.16 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.301 179.892 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.61 146.41 45.42 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.13 26.43 7.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.968 . . . . 0.0 109.245 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.7 p90 -156.89 -42.88 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -80.3 80.61 6.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.871 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 7' ' ' ASP . 5.8 t60 -109.77 -160.65 0.72 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.162 -0.961 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' HIS . 17.4 t70 51.94 171.47 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.292 -0.88 . . . . 0.0 109.681 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -102.73 90.0 3.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.919 -1.113 . . . . 0.0 109.542 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.94 48.31 0.72 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' A' ' 14' ' ' HIS . 2.3 t80 -140.95 -137.1 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -1.129 . . . . 0.0 109.497 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER 73.85 7.61 4.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.995 . . . . 0.0 109.358 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -103.37 -30.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 109.157 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 1.8 m80 -114.49 -39.96 3.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.11 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.545 ' HB2' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -61.57 -44.5 96.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -0.995 . . . . 0.0 110.021 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 7.8 mm100 -55.91 -16.46 4.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 109.992 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.12 -41.21 9.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.092 . . . . 0.0 109.551 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.92 -59.38 3.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.694 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -48.07 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.694 ' N ' HG12 ' A' ' 18' ' ' VAL . 42.1 t80 -26.47 -43.88 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.807 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.854 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -62.25 -60.73 3.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -46.26 -48.7 17.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.739 0.78 . . . . 0.0 109.885 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.34 -36.8 76.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.702 -0.624 . . . . 0.0 110.227 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.26 16.47 24.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 109.587 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.3 t -91.25 -64.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 93.47 36.87 5.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 75.99 71.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.389 -1.065 . . . . 0.0 109.63 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.527 ' HB2' HG13 ' A' ' 24' ' ' VAL . 11.5 t-20 -73.99 -16.11 61.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.397 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 74.02 159.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 0.0 109.215 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 0.24 14.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.36 -76.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -1.155 . . . . 0.0 109.183 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -73.54 -18.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.287 -0.883 . . . . 0.0 109.076 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 32' ' ' ILE . 1.9 mp -87.62 -38.18 11.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.298 -0.876 . . . . 0.0 109.047 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.28 67.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.52 -54.16 3.9 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.25 -1.147 . . . . 0.0 109.235 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -63.23 -33.19 74.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 36' ' ' VAL . 67.4 t -88.65 24.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.23 -70.77 1.14 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.95 59.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.74 2.55 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -1.147 . . . . 0.0 109.628 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.558 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.6 166.38 6.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -133.69 106.28 7.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.0 p90 -153.54 -36.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -32.19 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.534 0.683 . . . . 0.0 110.779 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 4' ' ' PHE . 36.2 m80 -105.38 124.61 49.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.617 -0.677 . . . . 0.0 109.179 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.4 OUTLIER -71.38 145.72 49.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER 43.44 75.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 76.29 0.05 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.67 ' CZ ' ' CG ' ' A' ' 14' ' ' HIS . 3.9 t80 179.19 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -1.142 . . . . 0.0 109.366 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.649 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 3.4 mt-10 -44.69 -28.45 0.62 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 109.16 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.656 ' HA ' HE22 ' A' ' 15' ' ' GLN . 7.6 t -114.92 -17.26 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.397 -0.814 . . . . 0.0 109.117 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.1 t-80 -87.9 -58.44 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.883 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.67 ' CG ' ' CZ ' ' A' ' 10' ' ' TYR . 22.1 t-80 -35.59 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.048 0.451 . . . . 0.0 110.934 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.656 HE22 ' HA ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -78.32 -53.82 6.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.007 -1.058 . . . . 0.0 109.825 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 3.0 mmtp -52.58 -23.9 7.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.368 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.874 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -75.44 -58.9 3.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -52.01 -76.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.699 ' N ' HG12 ' A' ' 18' ' ' VAL . 3.0 t80 -27.51 -41.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.656 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -63.35 -61.82 2.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.57 -48.59 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.762 0.792 . . . . 0.0 109.364 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.79 -42.71 79.94 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.86 -0.525 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.19 15.04 28.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.201 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 25' ' ' GLY . 2.7 t -98.02 -76.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.71 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 95.4 63.19 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' GLY . 54.5 m 43.07 49.09 5.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -1.089 . . . . 0.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -127.56 20.81 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 0.0 109.404 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.26 -148.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.368 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.91 55.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.81 -90.59 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.127 . . . . 0.0 109.237 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.73 -52.49 9.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -52.51 -39.13 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.63 0.728 . . . . 0.0 109.471 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.679 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -62.24 -37.44 94.56 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -74.86 0.1 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.29 -1.124 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -52.86 59.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 110.482 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 36' ' ' VAL . 9.5 t -82.65 28.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.074 -1.016 . . . . 0.0 110.953 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 33' ' ' GLY . . . -132.19 15.97 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 -12.54 61.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.08 -11.63 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.148 -1.207 . . . . 0.0 108.872 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 ' OXT' ' A' ' 40' ' ' VAL . 15.4 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.431 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' HD23 ' A' ' 17' ' ' LEU . 11.9 mmtt . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.879 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -78.11 -59.68 2.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -50.25 -75.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.708 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.94 -42.16 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.582 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.4 t80 -62.6 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.1 -47.49 6.08 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.599 0.714 . . . . 0.0 109.673 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.608 ' OE2' HG12 ' A' ' 18' ' ' VAL . 51.0 mt-10 -56.47 -46.91 80.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.653 -0.654 . . . . 0.0 109.969 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.364 0.602 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -78.61 -27.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.379 -0.826 . . . . 0.0 109.407 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.57 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.8 pt -59.44 -46.86 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.82 -25.11 21.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 34' ' ' LEU . 29.1 mt -79.49 -67.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -1.194 . . . . 0.0 109.773 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.5 ptp -50.37 -21.08 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.61 -0.681 . . . . 0.0 109.703 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.791 ' O ' HG12 ' A' ' 36' ' ' VAL . 91.7 t -88.45 28.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.884 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.85 -52.1 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -52.18 -76.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.33 -42.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.62 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.0 t80 -63.0 -61.63 2.26 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.01 -46.4 8.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.674 0.749 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.9 mt-10 -57.73 -43.11 85.09 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.826 -0.546 . . . . 0.0 109.934 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.907 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.261 0.553 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mp -54.53 -19.87 4.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.219 -0.926 . . . . 0.0 109.887 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' O ' ' C ' ' A' ' 33' ' ' GLY . 14.5 mt -64.71 -45.91 93.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.229 -0.919 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -44.64 -31.4 2.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -65.54 -77.55 0.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.437 -1.037 . . . . 0.0 109.928 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.501 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 1.8 ptt? -40.53 -26.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.814 -0.554 . . . . 0.0 110.285 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.814 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.3 t -84.15 30.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 110.208 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.861 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.515 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 mmmt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.449 0.642 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.863 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.53 -64.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -50.04 -71.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.542 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.11 -41.88 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.443 179.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.587 ' N ' ' O ' ' A' ' 18' ' ' VAL . 16.3 t80 -66.01 -63.67 1.03 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -49.22 -49.31 43.62 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.595 0.712 . . . . 0.0 110.192 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.08 -37.21 74.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.755 -0.591 . . . . 0.0 109.991 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.205 0.526 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 31' ' ' ILE . 1.7 mp -96.92 -22.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -93.13 -38.05 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -76.4 1.66 60.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 33' ' ' GLY . 36.0 mt -122.24 -49.87 2.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.604 ' HG3' HG23 ' A' ' 36' ' ' VAL . 18.4 ptm -54.58 -38.16 66.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.76 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.847 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.5 t -86.76 30.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.241 0.543 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.86 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -63.4 -55.66 22.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.4 t -50.76 -76.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.7 t80 -27.24 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.794 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 18' ' ' VAL . 12.6 t80 -63.68 -61.11 2.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -48.51 12.03 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.74 0.781 . . . . 0.0 109.618 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 55.8 mt-10 -58.37 -39.51 79.81 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.646 -0.659 . . . . 0.0 109.898 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.56 -33.75 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.27 -0.893 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 4.9 pt -64.68 -48.51 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 108.836 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -54.56 -29.47 48.22 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.49 -70.13 0.16 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.519 -0.989 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.488 ' HG2' HG23 ' A' ' 36' ' ' VAL . 10.8 ptt? -48.58 -31.46 6.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.743 -0.598 . . . . 0.0 109.807 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 36' ' ' VAL . 42.8 t -86.56 32.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.79 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.855 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.84 -55.1 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -46.31 -75.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.9 t80 -27.85 -40.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.767 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -66.24 -59.94 3.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.25 -47.2 12.84 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.785 0.803 . . . . 0.0 109.592 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 18' ' ' VAL . 49.3 mt-10 -58.0 -42.76 85.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.8 -0.562 . . . . 0.0 110.409 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HB ' HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -54.84 -58.74 3.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.2 mp -74.97 -37.26 40.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.0 -8.69 54.68 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -97.34 -53.2 3.54 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.282 -1.128 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.6 ptp -63.08 -26.81 69.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.832 ' O ' HG12 ' A' ' 36' ' ' VAL . 54.3 t -89.2 26.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.859 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.8 -62.68 1.41 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.693 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.57 -75.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.693 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -28.07 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.759 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . 33.4 t80 -66.46 -60.33 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.32 -49.37 12.86 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.737 0.779 . . . . 0.0 109.421 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 56.9 mt-10 -58.79 -40.82 85.16 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.228 0.537 . . . . 0.0 110.324 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.603 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.216 0.532 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.6 ' N ' HD13 ' A' ' 31' ' ' ILE . 1.9 mm -46.56 -41.59 4.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.203 -0.936 . . . . 0.0 109.478 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 mm -66.19 -39.06 83.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.76 -12.54 42.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 34' ' ' LEU . 31.9 mt -91.11 -66.15 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -1.19 . . . . 0.0 109.647 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -48.75 73.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 110.107 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.804 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.1 t -86.47 29.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.163 -0.961 . . . . 0.0 110.062 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 62.2 mmtt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.875 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.72 -50.45 57.41 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.68 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.8 t -51.96 -76.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.91 -42.06 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.84 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -63.56 -60.96 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.69 -45.5 9.79 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.854 0.835 . . . . 0.0 109.716 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 92.4 mt-10 -58.47 -42.45 87.51 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.787 -0.571 . . . . 0.0 109.849 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.114 -0.991 . . . . 0.0 109.859 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.176 0.512 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mt -50.84 -37.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.142 -0.974 . . . . 0.0 110.108 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.459 ' HA ' HD13 ' A' ' 32' ' ' ILE . 8.2 mm -73.25 -36.31 49.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.142 -0.974 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.04 6.13 57.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -107.54 -49.6 3.22 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -1.179 . . . . 0.0 109.728 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.484 ' HG3' HG23 ' A' ' 36' ' ' VAL . 24.1 ptt? -47.37 -31.73 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.438 -0.789 . . . . 0.0 110.031 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 36' ' ' VAL . 77.1 t -87.73 34.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.125 0.488 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -72.03 -57.06 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.78 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -26.51 -41.76 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.782 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.0 t80 -65.53 -60.9 2.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.12 -48.35 12.1 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 59.4 mt-10 -59.44 -40.5 86.97 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.903 -0.498 . . . . 0.0 110.323 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.586 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -82.97 -4.45 8.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.728 HD12 ' C ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -76.87 -37.64 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.307 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 32' ' ' ILE . . . -77.57 3.31 60.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 34' ' ' LEU . 41.1 mt -112.0 -45.71 3.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.1 ptm -52.39 -21.73 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.931 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.784 ' O ' HG12 ' A' ' 36' ' ' VAL . 96.7 t -84.9 28.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.253 0.549 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.83 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -62.94 -55.52 25.24 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.76 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.7 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.17 -41.87 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.4 t80 -65.3 -59.79 3.67 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.58 -44.85 9.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.864 0.84 . . . . 0.0 109.419 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.84 -43.28 90.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.218 0.532 . . . . 0.0 109.992 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.714 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.424 0.63 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.18 -39.32 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.47 -0.769 . . . . 0.0 109.21 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -79.68 -40.44 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.357 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.663 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -68.7 -4.97 42.72 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.5 tp -89.02 -48.87 7.12 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.211 . . . . 0.0 109.395 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.1 -11.67 57.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.738 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.826 ' O ' HG12 ' A' ' 36' ' ' VAL . 73.0 t -84.19 26.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 110.369 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.712 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -52.96 -57.89 8.79 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -46.92 -75.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.687 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -29.09 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.69 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -65.67 -59.98 3.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.42 -45.38 12.78 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.833 0.825 . . . . 0.0 109.699 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.67 -41.52 86.33 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.751 -0.593 . . . . 0.0 110.122 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 109.94 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.207 0.527 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.86 -58.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -74.94 -40.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.15 -8.03 41.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 34' ' ' LEU . 33.4 tp -98.34 -51.34 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.213 -1.169 . . . . 0.0 109.402 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 32' ' ' ILE . 12.1 ptp -57.83 -21.22 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.489 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 36' ' ' VAL . 53.0 t -86.15 25.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.89 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.86 -56.35 9.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -49.36 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.51 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.799 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . 21.8 t80 -64.55 -61.25 2.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.78 -48.02 8.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.795 0.807 . . . . 0.0 109.454 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 78.8 mt-10 -58.22 -42.31 86.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.213 0.53 . . . . 0.0 110.032 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.894 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 31' ' ' ILE . 1.7 mp -81.64 -25.65 9.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.111 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -70.24 -47.29 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.263 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -66.45 -8.22 44.28 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.8 tp -93.53 -47.38 6.87 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.302 -1.116 . . . . 0.0 109.633 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 2.8 ptt? -47.17 -29.73 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.074 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.795 ' O ' HG12 ' A' ' 36' ' ' VAL . 94.0 t -85.97 31.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.276 -0.89 . . . . 0.0 110.029 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.891 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -76.22 -60.66 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.4 t -49.7 -75.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -27.32 -40.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.759 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' VAL . 1.2 t80 -65.06 -60.68 2.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -49.94 11.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.749 0.785 . . . . 0.0 109.492 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 58.9 mt-10 -58.62 -38.56 78.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.745 -0.597 . . . . 0.0 109.994 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.73 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -70.69 -45.06 75.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.228 -0.92 . . . . 0.0 108.586 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -48.08 -61.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 109.516 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -39.61 -36.87 0.76 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 38.9 mt -55.27 -56.64 17.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.36 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 6.3 ptp -66.43 -21.27 66.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.504 -0.748 . . . . 0.0 109.495 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 36' ' ' VAL . 26.2 t -85.84 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.28 0.562 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.874 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -74.58 -58.66 3.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.75 -76.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.703 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t80 -25.88 -42.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.784 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.9 t80 -64.62 -61.76 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.91 -47.51 8.38 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.65 0.738 . . . . 0.0 109.641 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -58.3 -43.39 88.06 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.762 -0.586 . . . . 0.0 110.072 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.833 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -85.93 -28.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 108.737 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.05 -48.51 17.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.38 -8.42 50.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.3 tp -90.37 -50.44 5.96 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.359 -1.083 . . . . 0.0 109.373 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.518 ' HG3' HG23 ' A' ' 36' ' ' VAL . 4.9 ptm -64.6 -38.78 92.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.51 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.768 ' O ' HG12 ' A' ' 36' ' ' VAL . 41.8 t -87.45 17.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.141 -0.974 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.705 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.341 0.591 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.857 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.73 -57.93 3.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.707 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -51.2 -76.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.707 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.5 t80 -25.83 -42.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.778 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 18' ' ' VAL . 6.1 t80 -63.4 -62.55 1.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.63 -47.45 7.58 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.735 0.779 . . . . 0.0 109.823 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 67.4 mt-10 -58.62 -43.03 89.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.706 -0.621 . . . . 0.0 110.357 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 109.999 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.33 -22.24 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 3.9 pt -77.74 -45.08 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.305 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -61.7 -13.59 39.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 34' ' ' LEU . 37.4 mt -74.01 -49.48 24.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -1.185 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.6 ptm -62.75 -35.02 78.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.543 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.824 ' O ' HG12 ' A' ' 36' ' ' VAL . 55.0 t -93.82 24.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.177 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 67.1 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.856 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -73.11 -59.73 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.85 -75.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.57 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.669 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.1 t80 -63.72 -62.17 1.83 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.2 -47.26 9.21 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.796 0.807 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -58.82 -41.59 87.22 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.137 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.076 -1.015 . . . . 0.0 110.06 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.41 -20.34 26.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.053 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.0 mm -76.62 -45.05 33.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.41 -0.806 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.15 -34.76 87.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 34' ' ' LEU . 38.4 mt -71.03 -55.67 7.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -1.11 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -58.95 -26.73 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 109.689 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 36' ' ' VAL . 69.0 t -88.82 25.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.195 0.522 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.886 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.35 -59.37 3.46 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.09 -76.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.702 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.2 t80 -26.95 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.731 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' VAL . 2.1 t80 -65.77 -60.77 2.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.49 -48.73 10.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.789 0.804 . . . . 0.0 109.444 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -56.57 -47.69 78.95 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.788 -0.57 . . . . 0.0 110.015 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.215 0.531 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.02 -29.42 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.117 -0.989 . . . . 0.0 109.557 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -74.69 -47.24 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -70.73 -3.83 51.24 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.3 tp -98.71 -53.28 3.35 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.168 -1.196 . . . . 0.0 109.34 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.1 ptm -48.38 -22.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.82 ' O ' HG12 ' A' ' 36' ' ' VAL . 80.7 t -87.19 31.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.337 -0.852 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.652 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.878 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.93 -56.49 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -49.04 -76.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.59 -41.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . 3.7 t80 -64.98 -61.48 2.13 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -42.68 -47.47 5.35 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.901 0.858 . . . . 0.0 109.317 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.4 mt-10 -56.64 -45.37 81.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.193 0.521 . . . . 0.0 109.912 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.328 0.585 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 31' ' ' ILE . 1.1 mp -49.69 -30.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 8.9 pt -80.81 -47.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 108.838 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.56 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.74 -21.46 9.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 34' ' ' LEU . 27.2 mt -80.94 -67.15 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 5.4 ptt? -43.76 -25.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.668 -0.645 . . . . 0.0 110.045 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 36' ' ' VAL . 89.8 t -86.73 31.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -0.917 . . . . 0.0 109.893 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 5.3 mmmt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -71.4 -54.45 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.704 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -55.84 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.704 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.8 -42.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.981 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.6 t80 -64.11 -61.23 2.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.92 -46.92 8.32 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.819 0.818 . . . . 0.0 109.43 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.16 -43.3 87.35 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.83 -0.544 . . . . 0.0 109.707 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.254 0.549 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -42.26 -34.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.9 pt -71.15 -47.76 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.038 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.581 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -49.7 -24.8 6.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 34' ' ' LEU . 34.6 mt -62.32 -61.69 2.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -1.002 . . . . 0.0 109.4 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 18.9 ptt? -60.63 -18.36 52.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.746 -0.596 . . . . 0.0 109.741 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.798 ' O ' HG12 ' A' ' 36' ' ' VAL . 95.7 t -87.08 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.21 -0.932 . . . . 0.0 110.073 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.728 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.92 -59.38 3.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.694 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -48.07 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.694 ' N ' HG12 ' A' ' 18' ' ' VAL . 42.1 t80 -26.47 -43.88 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.807 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -62.25 -60.73 3.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -46.26 -48.7 17.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.739 0.78 . . . . 0.0 109.885 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.34 -36.8 76.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.702 -0.624 . . . . 0.0 110.227 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 109.587 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -73.54 -18.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.287 -0.883 . . . . 0.0 109.076 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 32' ' ' ILE . 1.9 mp -87.62 -38.18 11.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.298 -0.876 . . . . 0.0 109.047 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.28 67.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.52 -54.16 3.9 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.25 -1.147 . . . . 0.0 109.235 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -63.23 -33.19 74.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.804 ' O ' HG12 ' A' ' 36' ' ' VAL . 67.4 t -88.65 24.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.826 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 3.0 mmtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.399 0.619 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.874 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -75.44 -58.9 3.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -52.01 -76.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.699 ' N ' HG12 ' A' ' 18' ' ' VAL . 3.0 t80 -27.51 -41.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.656 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -63.35 -61.82 2.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.57 -48.59 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.762 0.792 . . . . 0.0 109.364 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.79 -42.71 79.94 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.86 -0.525 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.201 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.73 -52.49 9.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -52.51 -39.13 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.63 0.728 . . . . 0.0 109.471 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.679 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -62.24 -37.44 94.56 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -74.86 0.1 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.29 -1.124 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -52.86 59.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 110.482 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' VAL . 9.5 t -82.65 28.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.074 -1.016 . . . . 0.0 110.953 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 33' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.99 172.81 11.65 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.253 -0.904 . . . . 0.0 109.587 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 4' ' ' PHE . 1.1 tp10 -150.55 27.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 109.379 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' GLU . 2.8 p90 -40.71 -44.99 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HG3' ' C ' ' A' ' 4' ' ' PHE . 1.9 mtp180 -133.46 -144.11 0.22 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 67.69 22.09 9.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.285 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -121.38 106.86 11.83 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.379 -0.826 . . . . 0.0 109.437 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.407 ' C ' ' OE2' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -156.05 -144.66 0.14 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 108.981 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.72 -57.75 0.19 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 8.3 t80 -62.33 -105.06 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -1.096 . . . . 0.0 108.799 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 3.9 mt-10 77.89 7.45 2.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.854 -1.154 . . . . 0.0 110.739 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -96.11 -17.83 6.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.91 -1.119 . . . . 0.0 109.519 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.495 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -141.54 -49.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.502 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -47.32 -30.79 3.38 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.682 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 11' ' ' GLU . 32.2 mm-40 -66.2 -52.07 51.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.638 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' HD23 ' A' ' 17' ' ' LEU . 11.9 mmtt -51.67 -23.6 4.61 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 0.0 109.18 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -78.11 -59.68 2.68 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -50.25 -75.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.708 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.94 -42.16 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.582 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.932 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.4 t80 -62.6 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.1 -47.49 6.08 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.599 0.714 . . . . 0.0 109.673 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.608 ' OE2' HG12 ' A' ' 18' ' ' VAL . 51.0 mt-10 -56.47 -46.91 80.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.653 -0.654 . . . . 0.0 109.969 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.28 14.63 19.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 20' ' ' PHE . 8.0 t -92.51 -78.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.647 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 123.26 -47.35 1.03 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER 164.79 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -1.143 . . . . 0.0 109.642 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -126.1 -138.7 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.905 . . . . 0.0 109.123 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -103.68 160.8 14.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.4 -91.15 0.85 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.53 -87.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.304 -1.116 . . . . 0.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -78.61 -27.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.379 -0.826 . . . . 0.0 109.407 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.57 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.8 pt -59.44 -46.86 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.82 -25.11 21.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 34' ' ' LEU . 29.1 mt -79.49 -67.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -1.194 . . . . 0.0 109.773 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.5 ptp -50.37 -21.08 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.61 -0.681 . . . . 0.0 109.703 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.791 ' O ' HG12 ' A' ' 36' ' ' VAL . 91.7 t -88.45 28.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.322 -0.861 . . . . 0.0 109.733 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.97 45.96 0.52 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.24 -73.19 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.09 -32.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 11.0 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.523 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.408 0.623 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.23 144.14 28.31 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.683 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -112.43 94.21 4.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 109.217 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -49.2 3.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 109.756 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -96.16 -149.76 0.32 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 109.085 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' ARG . 3.6 t60 41.72 27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.762 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' ARG . 1.1 t0 -154.49 -150.81 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.288 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.1 p -118.6 -144.37 0.37 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.204 -0.935 . . . . 0.0 109.191 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 14' ' ' HIS . . . -121.29 -52.69 0.23 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 1.4 t80 -156.21 -119.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.079 . . . . 0.0 109.231 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 9.7 mt-10 -168.2 -59.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 0.0 109.243 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.1 t -82.81 -34.39 11.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.19 -0.944 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -118.67 60.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.77 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.586 ' CE1' ' HA3' ' A' ' 9' ' ' GLY . 7.3 t60 -172.17 -41.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.093 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 32.3 mm-40 -77.45 -32.91 54.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 108.796 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -85.24 -32.02 22.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.85 -52.1 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -52.18 -76.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.33 -42.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.62 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.735 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.0 t80 -63.0 -61.63 2.26 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.01 -46.4 8.34 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.674 0.749 . . . . 0.0 109.465 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.9 mt-10 -57.73 -43.11 85.09 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.826 -0.546 . . . . 0.0 109.934 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.36 15.92 19.91 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.8 t -90.0 -59.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.79 49.59 3.55 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m 46.39 58.78 4.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.434 ' HB2' HG13 ' A' ' 24' ' ' VAL . 1.4 t-20 -84.96 12.97 6.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -177.01 -176.68 0.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.688 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -161.96 58.31 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.69 -57.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -1.19 . . . . 0.0 109.634 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mp -54.53 -19.87 4.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.219 -0.926 . . . . 0.0 109.887 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.688 HD12 ' HA2' ' A' ' 29' ' ' GLY . 14.5 mt -64.71 -45.91 93.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.229 -0.919 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -44.64 -31.4 2.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -65.54 -77.55 0.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.437 -1.037 . . . . 0.0 109.928 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.501 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 1.8 ptt? -40.53 -26.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.814 -0.554 . . . . 0.0 110.285 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.814 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.3 t -84.15 30.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 110.208 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.56 -65.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.67 110.46 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.38 -17.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.515 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.306 0.574 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' HB3' ' HE1' ' A' ' 4' ' ' PHE . . . -73.38 170.87 14.17 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.566 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.13 99.34 4.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -125.4 -59.38 1.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.825 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 76.46 7.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.753 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.8 111.49 6.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -52.13 168.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.3 p -109.25 28.41 8.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.33 70.36 0.23 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 14' ' ' HIS . 5.5 t80 -74.27 -129.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 108.887 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 51.79 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.917 -1.114 . . . . 0.0 109.765 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' TYR . 3.4 t -47.35 -23.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 110.209 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -97.61 48.45 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.064 -1.023 . . . . 0.0 109.691 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.565 ' O ' HG23 ' A' ' 18' ' ' VAL . 43.3 t60 179.64 -61.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.463 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 38.3 mm-40 -56.57 -54.59 44.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.304 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 mmmt -42.35 -27.54 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -83.53 -64.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -50.04 -71.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.542 ' C ' ' O ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.11 -41.88 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.443 179.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 1.025 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.3 t80 -66.01 -63.67 1.03 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -49.22 -49.31 43.62 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.595 0.712 . . . . 0.0 110.192 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.08 -37.21 74.03 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.755 -0.591 . . . . 0.0 109.991 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.09 16.56 23.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.025 HG23 ' O ' ' A' ' 20' ' ' PHE . 8.2 t -92.28 -45.31 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.61 -41.95 2.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.629 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -172.08 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -1.066 . . . . 0.0 109.322 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.86 ' ND2' HG21 ' A' ' 24' ' ' VAL . 1.3 m-20 -65.32 86.24 0.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.473 -0.767 . . . . 0.0 109.395 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -52.71 -70.14 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.457 -0.777 . . . . 0.0 109.473 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.69 75.09 0.68 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.07 -61.23 1.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -1.101 . . . . 0.0 109.931 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 31' ' ' ILE . 1.7 mp -96.92 -22.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -93.13 -38.05 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 34' ' ' LEU . . . -76.4 1.66 60.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 33' ' ' GLY . 36.0 mt -122.24 -49.87 2.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -1.191 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.604 ' HG3' HG23 ' A' ' 36' ' ' VAL . 18.4 ptm -54.58 -38.16 66.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.76 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.847 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.5 t -86.76 30.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 34.12 4.13 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.45 -129.9 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.04 29.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -1.115 . . . . 0.0 109.443 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.507 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.7 32.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.193 -0.942 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -107.26 93.64 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 5' ' ' ARG . 0.9 OUTLIER -124.26 -174.19 2.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.858 . . . . 0.0 109.63 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' PHE . 2.0 mpt_? 61.92 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.91 166.17 16.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.628 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -145.12 137.47 25.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.0 109.326 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -75.74 81.24 2.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.594 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.18 84.77 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -105.35 -74.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.2 -1.177 . . . . 0.0 108.934 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 2.2 mt-10 64.49 -97.83 0.06 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.426 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.6 t -45.16 -24.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.682 -1.261 . . . . 0.0 109.742 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -100.4 47.58 0.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.504 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 1.0 OUTLIER 177.39 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.934 -1.104 . . . . 0.0 110.216 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 32.4 mm-40 -71.96 -57.7 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -58.35 -37.95 76.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.757 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.86 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -63.4 -55.66 22.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.4 t -50.76 -76.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.7 t80 -27.24 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.794 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.551 ' CD2' HG21 ' A' ' 24' ' ' VAL . 12.6 t80 -63.68 -61.11 2.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -48.51 12.03 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.74 0.781 . . . . 0.0 109.618 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 55.8 mt-10 -58.37 -39.51 79.81 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.646 -0.659 . . . . 0.0 109.898 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.68 15.84 26.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.752 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.551 HG21 ' CD2' ' A' ' 20' ' ' PHE . 2.5 t -101.91 -61.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 96.93 43.88 2.97 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 48.64 49.8 18.1 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.441 -1.035 . . . . 0.0 109.419 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 8.5 t-20 -57.18 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 66.74 79.97 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.76 29.33 0.75 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.02 -63.05 1.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -1.073 . . . . 0.0 109.533 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mp -51.56 -33.75 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.27 -0.893 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 4.9 pt -64.68 -48.51 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 108.836 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -54.56 -29.47 48.22 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.49 -70.13 0.16 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.519 -0.989 . . . . 0.0 109.815 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.488 ' HG2' HG23 ' A' ' 36' ' ' VAL . 10.8 ptt? -48.58 -31.46 6.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.743 -0.598 . . . . 0.0 109.807 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.69 ' O ' HG12 ' A' ' 36' ' ' VAL . 42.8 t -86.56 32.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -112.78 18.18 22.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.82 70.48 0.52 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.49 26.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -1.145 . . . . 0.0 109.527 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.352 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.487 ' HB1' ' CZ ' ' A' ' 4' ' ' PHE . . . -68.8 -178.65 1.24 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.238 -0.914 . . . . 0.0 109.547 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -148.53 25.28 0.97 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CZ ' ' HB1' ' A' ' 2' ' ' ALA . 2.2 p90 -124.48 176.96 6.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' A' ' 6' ' ' HIS . 3.4 mpt_? 66.28 76.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.481 ' CB ' ' O ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER 73.54 -167.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -148.13 -44.15 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.13 121.64 0.1 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.43 -68.47 1.65 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 17.1 t80 -120.85 -118.26 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -1.117 . . . . 0.0 109.157 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 7.4 mt-10 -164.87 -95.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.737 -1.227 . . . . 0.0 109.898 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 12' ' ' VAL . 3.8 t -50.83 -39.82 19.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.938 -1.101 . . . . 0.0 110.455 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 94.8 m-70 -109.82 68.89 0.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 110.237 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.528 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 5.3 t-80 177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.04 . . . . 0.0 110.277 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 38.9 mm-40 -57.18 -16.64 8.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 0.0 110.142 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -88.2 -32.49 18.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.053 . . . . 0.0 109.49 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.855 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.84 -55.1 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -46.31 -75.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.9 t80 -27.85 -40.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.767 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.732 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -66.24 -59.94 3.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.25 -47.2 12.84 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.785 0.803 . . . . 0.0 109.592 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 18' ' ' VAL . 49.3 mt-10 -58.0 -42.76 85.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.8 -0.562 . . . . 0.0 110.409 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.97 16.27 14.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.5 t -95.5 -57.6 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.81 39.16 5.3 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.78 63.23 2.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.442 -1.034 . . . . 0.0 109.585 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.63 ' HB2' HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -74.29 -76.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.534 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -119.71 119.94 35.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.568 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.21 27.66 0.62 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.48 -68.92 0.88 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HB ' HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -54.84 -58.74 3.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.2 mp -74.97 -37.26 40.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.0 -8.69 54.68 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -97.34 -53.2 3.54 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.282 -1.128 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.6 ptp -63.08 -26.81 69.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.832 ' O ' HG12 ' A' ' 36' ' ' VAL . 54.3 t -89.2 26.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 158.66 84.58 0.05 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.72 50.02 0.03 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.57 11.11 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.394 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.481 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.32 128.86 33.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.69 25.83 10.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.544 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -137.19 -50.04 0.63 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 110.035 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.72 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 110.082 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -179.52 101.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.763 . . . . 0.0 109.506 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.77 128.98 9.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.504 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.81 108.63 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 0.0 109.573 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.82 71.3 0.08 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 14' ' ' HIS . 20.2 t80 -118.85 -102.52 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -1.168 . . . . 0.0 109.748 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 16.0 mt-10 -162.6 -168.33 1.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.733 -1.23 . . . . 0.0 111.139 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.2 t -34.19 -34.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.218 0.532 . . . . 0.0 110.538 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -87.45 40.76 0.94 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.015 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . 76.5 t60 -159.09 -45.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.276 -0.89 . . . . 0.0 109.931 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.5 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 13.8 mm-40 -69.43 -48.63 60.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -58.85 -24.65 62.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.159 -0.963 . . . . 0.0 109.645 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.8 -62.68 1.41 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.693 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.57 -75.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.693 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -28.07 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.759 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.702 ' O ' HG23 ' A' ' 24' ' ' VAL . 33.4 t80 -66.46 -60.33 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.32 -49.37 12.86 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.737 0.779 . . . . 0.0 109.421 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 56.9 mt-10 -58.79 -40.82 85.16 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.228 0.537 . . . . 0.0 110.324 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.06 17.02 16.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.603 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.7 t -103.03 157.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -138.99 -47.03 0.06 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.84 35.07 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.321 -1.106 . . . . 0.0 109.197 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -45.32 -64.62 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -127.57 -33.06 2.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.581 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.52 88.57 1.76 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.13 -64.11 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.708 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.6 HD13 ' N ' ' A' ' 31' ' ' ILE . 1.9 mm -46.56 -41.59 4.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.203 -0.936 . . . . 0.0 109.478 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.2 mm -66.19 -39.06 83.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.76 -12.54 42.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 34' ' ' LEU . 31.9 mt -91.11 -66.15 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -1.19 . . . . 0.0 109.647 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -48.75 73.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 110.107 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.804 ' O ' HG12 ' A' ' 36' ' ' VAL . 78.1 t -86.47 29.67 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.163 -0.961 . . . . 0.0 110.062 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -135.51 57.64 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.82 33.74 2.43 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.42 6.97 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -1.159 . . . . 0.0 109.479 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 ' OXT' ' A' ' 40' ' ' VAL . 3.6 t . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.04 167.26 0.17 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.176 -0.952 . . . . 0.0 109.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -119.81 98.05 5.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 5' ' ' ARG . 12.1 p90 -161.46 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.659 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' N ' ' CG ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -108.87 90.24 3.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.776 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.51 -153.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 108.984 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -47.09 165.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.047 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -102.99 -142.44 0.36 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.154 -0.966 . . . . 0.0 109.347 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.09 -74.05 0.26 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.637 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 4.9 t80 -111.85 -93.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.04 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.637 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 9.9 mt-10 -156.26 -168.91 2.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.906 -1.121 . . . . 0.0 110.389 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.4 t -40.63 -29.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 O-C-N 121.597 -0.689 . . . . 0.0 109.832 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' O ' HD11 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -88.77 40.07 0.95 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 55.8 t-80 -158.05 -44.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.595 -0.691 . . . . 0.0 109.297 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 11' ' ' GLU . 2.7 mt-30 -81.63 -60.1 2.37 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.411 -0.805 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 62.2 mmtt -47.43 -26.12 1.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.085 -1.009 . . . . 0.0 109.091 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.72 -50.45 57.41 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.68 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.8 t -51.96 -76.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.91 -42.06 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.84 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.768 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -63.56 -60.96 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.69 -45.5 9.79 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.854 0.835 . . . . 0.0 109.716 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 92.4 mt-10 -58.47 -42.45 87.51 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.787 -0.571 . . . . 0.0 109.849 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.16 16.03 17.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.114 -0.991 . . . . 0.0 109.859 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 20' ' ' PHE . 5.6 t -91.14 164.88 2.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -82.4 -58.09 2.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.61 54.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.118 -1.225 . . . . 0.0 109.586 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.493 ' O ' HG21 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -97.09 -59.13 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.499 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -139.2 97.96 3.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.94 -86.49 1.21 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.99 -70.72 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.054 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mt -50.84 -37.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.142 -0.974 . . . . 0.0 110.108 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 27' ' ' ASN . 8.2 mm -73.25 -36.31 49.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.142 -0.974 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.04 6.13 57.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.0 tp -107.54 -49.6 3.22 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -1.179 . . . . 0.0 109.728 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.484 ' HG3' HG23 ' A' ' 36' ' ' VAL . 24.1 ptt? -47.37 -31.73 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.438 -0.789 . . . . 0.0 110.031 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.813 ' O ' HG12 ' A' ' 36' ' ' VAL . 77.1 t -87.73 34.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.47 -61.16 2.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 39' ' ' VAL . . . 106.3 26.85 5.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 40' ' ' VAL . 15.1 m 40.67 37.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.971 . . . . 0.0 109.768 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 39' ' ' VAL . 8.6 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.81 -1.091 . . . . 0.0 109.443 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.36 176.04 5.65 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.216 -0.927 . . . . 0.0 109.709 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.28 95.1 4.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.461 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' HG3' ' A' ' 5' ' ' ARG . 31.4 p90 -157.59 -36.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.557 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 22.9 mtt180 -60.26 86.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.425 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -115.39 146.11 41.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.1 OUTLIER -112.57 -61.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 4.7 t 72.64 58.28 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.47 74.49 0.02 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 12.0 t80 -90.45 -99.64 0.1 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 36.8 mt-10 -157.81 -154.11 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.939 -1.101 . . . . 0.0 110.228 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 12' ' ' VAL . 3.4 t -38.4 -35.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.493 -0.754 . . . . 0.0 110.381 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -86.2 40.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.1 -1.0 . . . . 0.0 109.183 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 9.4 t60 -164.81 -42.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 25.4 mm-40 -68.92 -51.21 42.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.517 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -58.24 -27.94 64.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.722 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -72.03 -57.06 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.9 t -48.78 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -26.51 -41.76 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.782 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.0 t80 -65.53 -60.9 2.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.12 -48.35 12.1 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 59.4 mt-10 -59.44 -40.5 86.97 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.903 -0.498 . . . . 0.0 110.323 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.42 15.49 15.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.586 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.1 t -100.51 -67.29 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 91.66 43.54 4.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.7 69.3 0.7 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -1.075 . . . . 0.0 109.237 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 1.5 t30 -81.76 78.63 8.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 1.7 ptpt 41.15 30.04 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.83 . . . . 0.0 110.194 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 81.82 1.25 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.34 -67.76 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -82.97 -4.45 8.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -76.87 -37.64 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.307 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 32' ' ' ILE . . . -77.57 3.31 60.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 34' ' ' LEU . 41.1 mt -112.0 -45.71 3.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -1.141 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.1 ptm -52.39 -21.73 3.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.627 -0.671 . . . . 0.0 109.931 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.784 ' O ' HG12 ' A' ' 36' ' ' VAL . 96.7 t -84.9 28.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.38 73.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.31 113.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -74.87 -38.64 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.226 -1.161 . . . . 0.0 109.092 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 39' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.313 0.577 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.02 171.25 12.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -123.29 98.69 5.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -128.31 -39.59 1.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.535 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -50.19 88.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.632 -0.667 . . . . 0.0 109.625 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.2 t-160 -125.17 23.64 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.89 -163.37 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 76.7 p -156.0 100.43 2.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.94 60.17 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -168.44 -131.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.105 -179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' TYR . 27.7 mt-10 79.23 6.86 2.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.98 -11.99 8.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.12 -45.86 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.865 . . . . 0.0 109.887 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' HA ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 t-160 -57.76 -23.37 51.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.244 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' NE2' ' HA ' ' A' ' 11' ' ' GLU . 51.1 mm-40 -60.36 -33.74 72.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.073 -1.017 . . . . 0.0 110.307 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -72.21 -39.36 68.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.855 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.83 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -62.94 -55.52 25.24 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.76 -76.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.7 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.17 -41.87 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.677 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.4 t80 -65.3 -59.79 3.67 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.58 -44.85 9.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.864 0.84 . . . . 0.0 109.419 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.84 -43.28 90.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.218 0.532 . . . . 0.0 109.992 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.98 16.22 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.714 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.5 t -96.8 160.54 2.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -89.53 -41.43 5.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.15 71.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -1.152 . . . . 0.0 109.445 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.53 6.09 25.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt 52.14 -173.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -129.08 50.75 0.88 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.88 -50.55 2.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.18 -39.32 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.47 -0.769 . . . . 0.0 109.21 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -79.68 -40.44 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.357 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.663 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -68.7 -4.97 42.72 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 38' ' ' GLY . 33.5 tp -89.02 -48.87 7.12 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.211 . . . . 0.0 109.395 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.1 -11.67 57.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.738 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.826 ' O ' HG12 ' A' ' 36' ' ' VAL . 73.0 t -84.19 26.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 110.369 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.55 67.05 0.53 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 34' ' ' LEU . . . -152.64 71.92 0.28 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 40' ' ' VAL . 8.5 m -137.62 -43.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -1.091 . . . . 0.0 109.479 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' N ' HG23 ' A' ' 39' ' ' VAL . 21.1 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.392 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.277 0.561 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.44 171.46 0.19 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.246 -0.909 . . . . 0.0 109.558 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.92 105.48 8.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 9.6 p90 -147.32 176.74 9.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.3 101.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' A' ' 6' ' ' HIS . 1.3 p-80 -117.83 162.5 18.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.602 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -146.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.18 -142.92 0.35 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.207 -0.933 . . . . 0.0 109.165 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.508 ' HA3' ' CD2' ' A' ' 14' ' ' HIS . . . -113.68 -70.21 0.53 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 6.7 t80 -179.75 -108.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 2.3 mt-10 -169.43 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.8 -1.187 . . . . 0.0 110.212 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.6 -39.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.904 -1.123 . . . . 0.0 110.11 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.03 58.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 1.8 t60 -175.0 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 41.0 mm-40 -62.77 -35.87 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.36 -0.837 . . . . 0.0 109.052 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.74 -42.44 77.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.394 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -52.96 -57.89 8.79 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -46.92 -75.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.687 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -29.09 -39.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.69 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -65.67 -59.98 3.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.42 -45.38 12.78 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.833 0.825 . . . . 0.0 109.699 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.67 -41.52 86.33 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.751 -0.593 . . . . 0.0 110.122 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.21 15.63 18.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 109.94 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 20' ' ' PHE . 5.1 t -89.44 -47.66 14.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 90.84 30.26 11.75 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 69.04 68.56 0.27 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.575 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -143.15 59.3 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.394 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -113.72 128.84 56.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 0.0 109.459 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . . . 156.78 85.68 0.05 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.35 -57.55 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 0.0 109.645 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.86 -58.66 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -74.94 -40.44 45.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA3' ' CA ' ' A' ' 29' ' ' GLY . . . -66.15 -8.03 41.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 34' ' ' LEU . 33.4 tp -98.34 -51.34 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.213 -1.169 . . . . 0.0 109.402 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.444 ' HG2' ' HA ' ' A' ' 32' ' ' ILE . 12.1 ptp -57.83 -21.22 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.489 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 36' ' ' VAL . 53.0 t -86.15 25.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 21.88 28.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.42 7.83 64.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -115.7 0.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -1.182 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.915 -1.04 . . . . 0.0 109.374 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.34 158.47 24.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.579 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -126.95 94.77 4.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CE2' ' HD3' ' A' ' 5' ' ' ARG . 9.2 p90 -171.38 -159.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.751 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.533 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 65.23 104.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.677 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -157.54 171.33 20.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.427 -0.795 . . . . 0.0 109.133 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.41 -73.01 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.512 ' HA ' ' NE2' ' A' ' 14' ' ' HIS . 45.6 t 47.47 64.62 1.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.447 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.4 41.09 0.1 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' HB3' ' CB ' ' A' ' 14' ' ' HIS . 8.6 t80 -106.54 -102.14 0.34 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -1.221 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.54 ' HG3' ' CD1' ' A' ' 10' ' ' TYR . 57.9 mt-10 -157.44 -166.94 2.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.72 -1.238 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' GLU . 3.6 t -39.33 -34.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.764 -0.585 . . . . 0.0 110.043 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -85.64 39.63 0.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 108.752 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.566 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . 9.4 t60 -158.42 -42.76 0.06 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.466 -0.771 . . . . 0.0 109.589 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 25.5 mm-40 -65.39 -9.71 27.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -0.935 . . . . 0.0 109.344 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -98.43 -35.7 10.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.349 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.86 -56.35 9.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.8 t -49.36 -76.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -26.51 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.799 179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.896 ' O ' HG23 ' A' ' 24' ' ' VAL . 21.8 t80 -64.55 -61.25 2.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.78 -48.02 8.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.795 0.807 . . . . 0.0 109.454 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 78.8 mt-10 -58.22 -42.31 86.0 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.213 0.53 . . . . 0.0 110.032 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.2 17.35 17.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.894 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.4 t -90.51 159.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -94.16 -53.29 1.76 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 p -168.96 63.45 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -1.125 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.32 65.31 9.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.613 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -51.08 163.37 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.24 76.23 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.03 -54.42 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -1.095 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' ILE . 1.7 mp -81.64 -25.65 9.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.111 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -70.24 -47.29 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.263 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -66.45 -8.22 44.28 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.8 tp -93.53 -47.38 6.87 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.302 -1.116 . . . . 0.0 109.633 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 2.8 ptt? -47.17 -29.73 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.074 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.795 ' O ' HG12 ' A' ' 36' ' ' VAL . 94.0 t -85.97 31.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.276 -0.89 . . . . 0.0 110.029 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.05 10.59 5.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.82 85.27 0.36 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' A' ' 40' ' ' VAL . 29.3 m -130.0 32.34 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.219 -1.165 . . . . 0.0 109.392 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' O ' HG22 ' A' ' 40' ' ' VAL . 15.0 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.367 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' HB1' ' CE2' ' A' ' 4' ' ' PHE . . . -47.63 130.88 14.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HB3' HG21 ' A' ' 31' ' ' ILE . 2.6 tt0 -131.99 24.71 4.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 45.9 p90 -70.99 156.31 39.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.067 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' PHE . 1.7 mpt_? 68.27 116.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 109.114 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.426 ' C ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -43.47 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.99 -149.96 0.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -149.48 116.28 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.181 -0.949 . . . . 0.0 109.3 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 8' ' ' SER . . . -43.82 -50.79 7.18 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.1 t80 -150.38 -128.48 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.161 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.544 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 15.2 mt-10 -167.65 -37.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.826 -1.171 . . . . 0.0 109.787 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.53 -37.79 7.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.155 -0.965 . . . . 0.0 109.838 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' HIS . 31.5 m170 -101.78 -49.39 3.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.074 -1.016 . . . . 0.0 110.059 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 11.8 t-160 -42.92 -29.95 0.37 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.967 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 30.6 mm-40 -66.45 -54.85 19.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.633 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -47.15 -26.58 1.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.372 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.891 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -76.22 -60.66 2.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 19' ' ' PHE . 2.4 t -49.7 -75.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -27.32 -40.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.759 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.931 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.2 t80 -65.06 -60.68 2.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -45.1 -49.94 11.42 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.749 0.785 . . . . 0.0 109.492 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 58.9 mt-10 -58.62 -38.56 78.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.745 -0.597 . . . . 0.0 109.994 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.12 16.77 25.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.73 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 20' ' ' PHE . 5.0 t -90.08 -71.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 143.44 -48.88 0.73 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -173.84 46.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -1.195 . . . . 0.0 109.772 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 33.1 t30 -46.7 -75.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 109.128 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 76.58 133.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 109.77 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.4 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.04 -88.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -1.091 . . . . 0.0 109.32 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -70.69 -45.06 75.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.228 -0.92 . . . . 0.0 108.586 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 35' ' ' MET . 1.8 mp -48.08 -61.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 109.516 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . -39.61 -36.87 0.76 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 38.9 mt -55.27 -56.64 17.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.36 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 6.3 ptp -66.43 -21.27 66.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.504 -0.748 . . . . 0.0 109.495 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 36' ' ' VAL . 26.2 t -85.84 29.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.24 -79.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.79 49.53 28.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -102.27 18.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.497 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 40' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.7 179.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.064 -1.023 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -178.82 30.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.704 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 5' ' ' ARG . 37.2 p90 -96.78 -43.13 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.545 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.597 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -116.2 -148.97 0.44 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.152 -0.967 . . . . 0.0 109.049 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.85 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 0.0 109.557 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -120.46 -86.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.371 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -178.01 109.31 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.93 -89.1 1.32 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 4.4 t80 -131.65 -135.24 0.19 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.182 . . . . 0.0 109.3 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 21.8 mt-10 -164.02 -38.38 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.892 -1.13 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -93.23 -14.06 8.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.192 -0.943 . . . . 0.0 109.846 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 14' ' ' HIS . 1.2 t60 -129.45 -57.71 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.117 -0.989 . . . . 0.0 109.768 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 18.6 t-80 -42.89 -29.7 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 11' ' ' GLU . 39.1 mm-40 -73.34 -50.85 19.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.787 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -55.91 -23.78 33.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.874 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -74.58 -58.66 3.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.75 -76.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.703 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t80 -25.88 -42.61 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.784 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' N ' ' O ' ' A' ' 18' ' ' VAL . 49.9 t80 -64.62 -61.76 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.91 -47.51 8.38 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.65 0.738 . . . . 0.0 109.641 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -58.3 -43.39 88.06 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.762 -0.586 . . . . 0.0 110.072 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.47 16.4 10.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.833 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.78 HG12 ' N ' ' A' ' 25' ' ' GLY . 3.7 t -106.51 -82.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.78 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 119.83 -46.56 1.11 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER 167.13 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -1.138 . . . . 0.0 109.303 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -75.82 -65.35 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 151.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.408 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.28 47.88 27.37 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.97 -61.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -1.161 . . . . 0.0 109.291 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -85.93 -28.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 108.737 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.05 -48.51 17.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.38 -8.42 50.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.3 tp -90.37 -50.44 5.96 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.359 -1.083 . . . . 0.0 109.373 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.518 ' HG3' HG23 ' A' ' 36' ' ' VAL . 4.9 ptm -64.6 -38.78 92.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 109.51 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 ' O ' HG12 ' A' ' 36' ' ' VAL . 41.8 t -87.45 17.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.141 -0.974 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.72 31.24 4.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.68 97.36 0.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG23 ' N ' ' A' ' 40' ' ' VAL . 4.2 m -94.8 -37.72 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -1.135 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.506 ' OXT' HG13 ' A' ' 40' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.27 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 5' ' ' ARG . . . -81.85 117.65 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 109.735 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.16 7.58 17.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.676 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 5' ' ' ARG . 22.7 p90 -91.55 -32.49 15.52 Favored 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.732 -0.605 . . . . 0.0 109.719 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.613 ' HD2' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -83.16 78.08 9.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -115.36 139.46 49.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.5 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.52 -159.11 0.56 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 109.553 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 t -124.32 59.1 1.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.07 -68.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 14' ' ' HIS . 1.6 t80 -157.38 -143.83 0.12 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -1.152 . . . . 0.0 109.256 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 29.1 mt-10 69.77 0.62 3.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.88 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.7 -17.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.884 -1.135 . . . . 0.0 109.299 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -130.64 54.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -170.26 -40.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.563 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -72.38 -31.33 65.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -74.29 -25.7 59.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.487 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.857 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.73 -57.93 3.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.707 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -51.2 -76.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.707 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.5 t80 -25.83 -42.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.778 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 18' ' ' VAL . 6.1 t80 -63.4 -62.55 1.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.63 -47.45 7.58 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.735 0.779 . . . . 0.0 109.823 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 67.4 mt-10 -58.62 -43.03 89.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.706 -0.621 . . . . 0.0 110.357 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.06 15.11 6.4 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 109.999 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 2.9 t -116.79 159.09 17.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -102.49 -38.35 3.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.74 65.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -1.145 . . . . 0.0 109.234 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -51.79 -92.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.592 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -178.74 -77.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.41 64.5 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.8 -54.89 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.243 . . . . 0.0 109.391 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.33 -22.24 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.872 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.546 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 3.9 pt -77.74 -45.08 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.305 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -61.7 -13.59 39.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 34' ' ' LEU . 37.4 mt -74.01 -49.48 24.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -1.185 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.6 ptm -62.75 -35.02 78.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.543 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 ' O ' HG12 ' A' ' 36' ' ' VAL . 55.0 t -93.82 24.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.177 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.89 -45.97 11.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.53 -129.17 2.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' O ' ' HB ' ' A' ' 40' ' ' VAL . 14.4 m -118.44 38.11 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -1.143 . . . . 0.0 109.406 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 39' ' ' VAL . 5.1 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.41 119.63 14.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -0.879 . . . . 0.0 109.553 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 3' ' ' GLU . 9.0 tt0 -94.04 27.26 2.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -140.88 -54.78 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.467 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -126.47 -154.74 0.65 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.46 ' O ' ' C ' ' A' ' 7' ' ' ASP . 2.3 m-70 -120.25 134.91 55.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.027 -1.046 . . . . 0.0 109.836 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' HIS . 32.6 t0 37.91 -130.1 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.638 -0.664 . . . . 0.0 110.23 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.99 125.51 2.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 109.084 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.58 -55.09 28.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CB ' ' HB2' ' A' ' 14' ' ' HIS . 0.9 OUTLIER -117.68 -132.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.238 . . . . 0.0 110.213 -179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 28.8 mt-10 -163.89 -32.93 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' N ' HE22 ' A' ' 15' ' ' GLN . 3.7 t -110.1 -26.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 121.057 -1.027 . . . . 0.0 110.603 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -114.87 -28.76 6.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.622 -1.298 . . . . 0.0 111.22 -178.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 10' ' ' TYR . 52.5 t-80 -60.54 -11.98 8.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.011 -1.056 . . . . 0.0 110.357 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.494 ' NE2' ' C ' ' A' ' 11' ' ' GLU . 2.7 mp0 -85.63 -51.38 6.51 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.492 -0.755 . . . . 0.0 109.708 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 16' ' ' LYS . 67.1 mmtt -55.3 -26.13 38.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.112 -0.993 . . . . 0.0 109.248 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.856 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -73.11 -59.73 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -48.85 -75.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -27.57 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.669 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.822 ' O ' HG23 ' A' ' 24' ' ' VAL . 49.1 t80 -63.72 -62.17 1.83 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.2 -47.26 9.21 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.796 0.807 . . . . 0.0 109.749 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -58.82 -41.59 87.22 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.137 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 13.93 23.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.076 -1.015 . . . . 0.0 110.06 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.8 t -86.79 159.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -99.75 -52.33 1.21 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -171.56 58.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -1.156 . . . . 0.0 109.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -99.24 61.23 1.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -113.43 144.19 43.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.176 -0.953 . . . . 0.0 109.634 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.14 45.95 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.7 -82.61 0.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -1.147 . . . . 0.0 109.505 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.41 -20.34 26.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.053 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.0 mm -76.62 -45.05 33.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.41 -0.806 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.15 -34.76 87.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 34' ' ' LEU . 38.4 mt -71.03 -55.67 7.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -1.11 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -58.95 -26.73 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 109.689 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 36' ' ' VAL . 69.0 t -88.82 25.82 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.88 74.67 1.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.14 -25.1 14.97 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 40' ' ' VAL . 23.7 m -138.47 -46.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -1.202 . . . . 0.0 109.687 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' HG23 ' A' ' 39' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 109.587 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.16 136.01 56.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -100.53 30.75 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -167.69 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.103 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 6' ' ' HIS . 1.5 tpt180 -72.49 -145.37 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.09 -1.006 . . . . 0.0 109.363 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 5' ' ' ARG . 4.7 m170 47.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.596 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -79.4 -78.92 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.661 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 56.39 50.98 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 109.358 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.35 70.96 1.03 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 13.5 t80 -91.78 -97.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -1.187 . . . . 0.0 109.733 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 67.7 mt-10 -157.5 -145.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.856 -1.152 . . . . 0.0 110.073 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 11' ' ' GLU . 4.4 t -37.77 -41.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.05 45.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 7' ' ' ASP . 11.6 t60 -166.12 -40.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.945 . . . . 0.0 110.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 29.2 mm-40 -67.7 -62.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -44.9 -35.93 3.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.886 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -67.35 -59.37 3.46 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -49.09 -76.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.702 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.2 t80 -26.95 -41.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.731 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.1 t80 -65.77 -60.77 2.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -44.49 -48.73 10.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.789 0.804 . . . . 0.0 109.444 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -56.57 -47.69 78.95 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.788 -0.57 . . . . 0.0 110.015 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 14.51 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.818 HG12 ' N ' ' A' ' 25' ' ' GLY . 3.4 t -108.32 -84.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.818 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 128.98 -38.37 2.04 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.613 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -174.2 59.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -1.22 . . . . 0.0 109.963 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB2' HG11 ' A' ' 24' ' ' VAL . 2.4 t30 -67.45 -57.52 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 109.23 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.15 173.13 15.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.399 -0.813 . . . . 0.0 109.189 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.41 83.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.8 -58.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -1.077 . . . . 0.0 109.916 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.02 -29.42 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.117 -0.989 . . . . 0.0 109.557 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.2 pt -74.69 -47.24 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -70.73 -3.83 51.24 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.3 tp -98.71 -53.28 3.35 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.168 -1.196 . . . . 0.0 109.34 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 10.1 ptm -48.38 -22.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.82 ' O ' HG12 ' A' ' 36' ' ' VAL . 80.7 t -87.19 31.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.337 -0.852 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.69 20.02 21.41 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.05 -12.21 3.87 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 120.999 -1.295 . . . . 0.0 109.933 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.18 43.6 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.101 -1.235 . . . . 0.0 109.505 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HB ' HG13 ' A' ' 36' ' ' VAL . 13.7 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.38 132.69 35.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 4' ' ' PHE . 2.8 mt-10 -67.77 -10.73 55.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 0.0 108.557 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLU . 1.5 t80 36.1 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 110.645 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' HIS . 20.8 mmt180 -99.42 -142.54 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.477 -0.764 . . . . 0.0 109.239 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER 58.8 153.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.256 -0.903 . . . . 0.0 109.092 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 165.03 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 0.0 109.27 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -154.29 86.29 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.26 -71.14 0.21 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 6.3 t80 -173.01 -96.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -1.088 . . . . 0.0 109.496 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.604 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 28.1 mt-10 -160.56 -173.05 3.78 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 110.575 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' GLU . 6.8 t -37.79 -28.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.779 -0.576 . . . . 0.0 110.453 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -88.28 38.21 0.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.0 108.458 178.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . 27.8 t60 -154.22 -46.02 0.09 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.521 -0.737 . . . . 0.0 109.316 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.51 ' NE2' ' C ' ' A' ' 11' ' ' GLU . 1.9 mt-30 -80.97 -45.66 16.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.531 -0.73 . . . . 0.0 109.667 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -62.55 -26.75 68.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -73.93 -56.49 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.712 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.0 t -49.04 -76.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.59 -41.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.977 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.7 t80 -64.98 -61.48 2.13 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -42.68 -47.47 5.35 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.901 0.858 . . . . 0.0 109.317 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 19' ' ' PHE . 89.4 mt-10 -56.64 -45.37 81.62 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.193 0.521 . . . . 0.0 109.912 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.96 15.99 22.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 109.759 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 20' ' ' PHE . 10.7 t -87.66 157.89 3.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.643 -0.66 . . . . 0.0 109.238 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -60.95 -56.14 25.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -171.2 51.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' HB2' HG11 ' A' ' 24' ' ' VAL . 4.1 t-20 -51.56 -52.45 47.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.223 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -47.38 139.83 6.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.558 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.55 -90.9 0.29 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.61 -84.37 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -1.14 . . . . 0.0 109.77 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 31' ' ' ILE . 1.1 mp -49.69 -30.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 8.9 pt -80.81 -47.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 108.838 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.56 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -52.74 -21.46 9.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 34' ' ' LEU . 27.2 mt -80.94 -67.15 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 5.4 ptt? -43.76 -25.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.668 -0.645 . . . . 0.0 110.045 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 36' ' ' VAL . 89.8 t -86.73 31.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -0.917 . . . . 0.0 109.893 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 81.49 0.1 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.33 -58.19 2.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.7 m -128.18 48.13 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -1.156 . . . . 0.0 109.76 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.6 t . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.428 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.07 124.16 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.924 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.06 24.47 11.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.567 ' CE2' ' HG2' ' A' ' 5' ' ' ARG . 8.4 p90 -131.04 -33.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 109.826 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.567 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 25.9 mmm-85 -67.11 -137.2 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.26 -0.9 . . . . 0.0 109.275 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' CG ' ' C ' ' A' ' 5' ' ' ARG . 24.2 m80 -150.43 -158.54 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 109.884 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -58.54 -21.07 51.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 0.0 109.74 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.8 p -69.15 84.77 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.095 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.66 -66.64 1.53 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 9.5 t80 -110.13 -118.86 0.28 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.113 -1.228 . . . . 0.0 109.845 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 10' ' ' TYR . 9.1 mt-10 -163.26 -100.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.747 -1.221 . . . . 0.0 109.896 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' H ' ' A' ' 12' ' ' VAL . 5.1 t -53.49 -34.52 23.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 O-C-N 120.841 -1.162 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -103.75 60.85 0.75 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.55 ' HB3' ' NE2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER 175.91 -60.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.485 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.55 ' NE2' ' HB3' ' A' ' 14' ' ' HIS . 17.1 mm-40 -63.78 -32.0 73.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 109.147 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 5.3 mmmt -71.98 -24.84 61.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -71.4 -54.45 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.704 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.3 t -55.84 -78.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.704 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -26.8 -42.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.981 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' VAL . 4.6 t80 -64.11 -61.23 2.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.92 -46.92 8.32 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.819 0.818 . . . . 0.0 109.43 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -58.16 -43.3 87.35 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.83 -0.544 . . . . 0.0 109.707 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 16.42 15.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.849 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 25' ' ' GLY . 2.5 t -100.02 161.71 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' A' ' 24' ' ' VAL . . . -147.15 -46.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.28 43.4 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.405 -1.056 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 28' ' ' LYS . 8.9 m120 -107.17 31.77 5.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.749 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' CG ' HD13 ' A' ' 31' ' ' ILE . 0.6 OUTLIER 50.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.86 10.07 3.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 31' ' ' ILE . . . -129.48 -60.91 1.04 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.112 -1.228 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD13 ' CG ' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -42.26 -34.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 33' ' ' GLY . 5.9 pt -71.15 -47.76 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.038 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.581 ' N ' ' CG1' ' A' ' 32' ' ' ILE . . . -49.7 -24.8 6.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 34' ' ' LEU . 34.6 mt -62.32 -61.69 2.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.496 -1.002 . . . . 0.0 109.4 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' ILE . 18.9 ptt? -60.63 -18.36 52.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.746 -0.596 . . . . 0.0 109.741 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.798 ' O ' HG12 ' A' ' 36' ' ' VAL . 95.7 t -87.08 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.21 -0.932 . . . . 0.0 110.073 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.09 52.75 0.82 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.46 121.32 0.89 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.74 12.16 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -1.128 . . . . 0.0 109.529 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.301 179.892 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.61 146.41 45.42 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.13 26.43 7.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.968 . . . . 0.0 109.245 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.7 p90 -156.89 -42.88 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -80.3 80.61 6.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.871 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 7' ' ' ASP . 5.8 t60 -109.77 -160.65 0.72 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.162 -0.961 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' HIS . 17.4 t70 51.94 171.47 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.292 -0.88 . . . . 0.0 109.681 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -102.73 90.0 3.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.919 -1.113 . . . . 0.0 109.542 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.94 48.31 0.72 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' A' ' 14' ' ' HIS . 2.3 t80 -140.95 -137.1 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -1.129 . . . . 0.0 109.497 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER 73.85 7.61 4.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.107 -0.995 . . . . 0.0 109.358 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -103.37 -30.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 109.157 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 1.8 m80 -114.49 -39.96 3.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.11 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.545 ' HB2' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -61.57 -44.5 96.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -0.995 . . . . 0.0 110.021 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 32.2 mm-40 -55.91 -16.46 4.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 109.992 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.12 -41.21 9.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.092 . . . . 0.0 109.551 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.92 -59.38 3.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.694 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.1 t -48.07 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.694 ' N ' HG12 ' A' ' 18' ' ' VAL . 42.1 t80 -26.47 -43.88 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.807 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.854 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -62.25 -60.73 3.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -46.26 -48.7 17.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.739 0.78 . . . . 0.0 109.885 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.34 -36.8 76.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.702 -0.624 . . . . 0.0 110.227 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.26 16.47 24.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 109.587 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.3 t -91.25 -64.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . 93.47 36.87 5.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 75.99 71.6 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.389 -1.065 . . . . 0.0 109.63 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.527 ' HB2' HG13 ' A' ' 24' ' ' VAL . 11.5 t-20 -73.99 -16.11 61.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.118 -0.989 . . . . 0.0 109.397 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 74.02 159.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 0.0 109.215 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 0.24 14.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.36 -76.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -1.155 . . . . 0.0 109.183 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.431 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -73.54 -18.19 17.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.287 -0.883 . . . . 0.0 109.076 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 32' ' ' ILE . 1.9 mp -87.62 -38.18 11.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.298 -0.876 . . . . 0.0 109.047 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.83 -10.28 67.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.52 -54.16 3.9 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.25 -1.147 . . . . 0.0 109.235 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -63.23 -33.19 74.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.804 ' O ' HG12 ' A' ' 36' ' ' VAL . 67.4 t -88.65 24.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.23 -70.77 1.14 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.95 59.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.74 2.55 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -1.147 . . . . 0.0 109.628 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.558 -179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.6 166.38 6.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -133.69 106.28 7.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.0 p90 -153.54 -36.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -32.19 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.534 0.683 . . . . 0.0 110.779 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 4' ' ' PHE . 36.2 m80 -105.38 124.61 49.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.617 -0.677 . . . . 0.0 109.179 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 8' ' ' SER . 0.4 OUTLIER -71.38 145.72 49.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER 43.44 75.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 76.29 0.05 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.67 ' CZ ' ' CG ' ' A' ' 14' ' ' HIS . 3.9 t80 179.19 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -1.142 . . . . 0.0 109.366 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.499 ' O ' ' OE1' ' A' ' 15' ' ' GLN . 3.4 mt-10 -44.69 -28.45 0.62 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 109.16 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.92 -17.26 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.397 -0.814 . . . . 0.0 109.117 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.55 ' CD2' HD21 ' A' ' 17' ' ' LEU . 3.6 t60 -87.9 -58.44 2.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 109.883 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.67 ' CG ' ' CZ ' ' A' ' 10' ' ' TYR . 22.1 t-80 -35.59 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.048 0.451 . . . . 0.0 110.934 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 13' ' ' HIS . 3.6 mp0 -78.32 -53.82 6.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.007 -1.058 . . . . 0.0 109.825 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 3.0 mmtp -52.58 -23.9 7.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.368 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.874 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -75.44 -58.9 3.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 19' ' ' PHE . 3.2 t -52.01 -76.49 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.699 ' N ' HG12 ' A' ' 18' ' ' VAL . 3.0 t80 -27.51 -41.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.656 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -63.35 -61.82 2.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 18' ' ' VAL . . . -43.57 -48.59 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.762 0.792 . . . . 0.0 109.364 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.79 -42.71 79.94 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.86 -0.525 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.19 15.04 28.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.201 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 25' ' ' GLY . 2.7 t -98.02 -76.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.71 ' N ' HG12 ' A' ' 24' ' ' VAL . . . 95.4 63.19 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' GLY . 54.5 m 43.07 49.09 5.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -1.089 . . . . 0.0 109.582 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -127.56 20.81 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 0.0 109.404 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.26 -148.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.368 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.91 55.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.81 -90.59 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.127 . . . . 0.0 109.237 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.73 -52.49 9.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -52.51 -39.13 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.63 0.728 . . . . 0.0 109.471 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.679 ' H ' HD13 ' A' ' 32' ' ' ILE . . . -62.24 -37.44 94.56 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -74.86 0.1 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.29 -1.124 . . . . 0.0 110.575 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.87 -52.86 59.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 110.482 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' VAL . 9.5 t -82.65 28.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.074 -1.016 . . . . 0.0 110.953 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 33' ' ' GLY . . . -132.19 15.97 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 -12.54 61.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.08 -11.63 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.148 -1.207 . . . . 0.0 108.872 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG12 ' OXT' ' A' ' 40' ' ' VAL . 15.4 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.431 179.905 . . . . . . . . 1 1 . 1 stop_ save_